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Abstract 
Recent evidence suggests that delivering human mesenchymal stem cells 
(hMSCs) to the infarcted heart reduces infarct size and improves ventricular 
performance. However, cell delivery systems have critical limitations such as 
inefficient cell retention, poor survival, and lack targeted localization. Our 
laboratories have recently developed a method to produce discrete fibrin 
microthreads that can be attached to a needle and delivered to a precise location 
within the heart wall.  We hypothesize that fibrin microthreads will support 
hMSC proliferation, survival and retention of multipotency, and may therefore 
facilitate targeted hMSC delivery to injured tissues such as infarcted 
myocardium.  To test this hypothesis, we bundled 100 μm diameter 
microthreads to provide grooves to encourage initial cell attachment.  We seeded 
hMSCs onto the microthread bundles by applying 50,000 cells in 100 μL of 
media.  The number of cells adhered to the microthreads was determined up to 5 
days in culture. Cell density on the fibrin microthreads increased over time in 
culture, achieving an average density of 730 ± 101 cells/mm2.  A LIVE/DEAD 
assay confirmed that the cells were viable and Ki-67 staining verified the increase 
in cell number over time was due to proliferation.  Additionally, functional 
differentiation assays suggested the hMSCs cultured on microthreads retained 
their ability to differentiate into adipocytes and osteocytes. The results of this 
study suggest that delivering 1 to 4 cell seeded microthreads to the infarcted rat 
myocardium will provide a quantity of cells that has been shown to produce 
positive improvement in mechanical function. Additionally these findings 
suggest that cell-seeded microthreads may serve a platform technology to 
improve localized delivery of viable cells to infarcted myocardium to promote 
functional tissue regeneration.  
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Chapter 1: Introduction 
The heart is the central pump vital to the function of the circulatory 
system. It is responsible for pumping oxygen and nutrient rich blood through the 
blood vessels to feed all the body’s organs and tissues. With such a crucial role, 
the health of the heart is of utmost importance to maintaining an individual’s 
overall well being. This overall well being can be severely compromised if blood 
supply to a region of heart tissue is blocked, producing an infarction. This results 
in cardiac myocyte death which ultimately forms a scarred region of non 
contractile tissue, diminishing the volume of blood pumped per minute (cardiac 
output) by the heart [1, 28, 30].  
The heart is unable to repair itself after infarction. If left untreated, the 
scarred region of dead tissue will thin and resulting in remodeling of left 
ventricular chamber dimensions [1]. The ejection fraction, defined as the fraction 
of blood within the ventricle that is ejected with each stroke of the heart, declines 
with infarct size. However, compensatory responses work to maintain a normal 
stroke volume. The extra pressure and volume generated by the compensatory 
response causes stress in the ventricular wall to increase. This puts the ventricle 
at risk of aneurysm and rupture [1]. Current medical interventions only treat the 
effects of infarction by reshaping the heart from the dilated, spherical shape, back 
to the original, efficient elliptical shape.  Procedures such as direct linear closure 
and endocardial patch plasty remove the area of infarcted myocardium and 
either suture the sides of the heart wall back together or insert a synthetic patch 
in place of the excised myocardium [2-4]. While these procedures restore 
ventricular geometry and pressures, they do not address the basic issue of 
regenerating the lost myocardium. Instead, the area continues to be a region of 
scarred tissue, not contributing to the overall work of the heart.   
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Cellular therapy has emerged as a technique to facilitate the regeneration 
of new, contractile tissue to replace the infarcted region and prevent pathological 
ventricular remodeling. Recent evidence suggests that the delivery of human 
mesenchymal stem cells (hMSCs) to the infarcted heart reduces infarct size and 
improves ventricular performance [5-10]. However, current cell delivery systems 
have critical limitations such as inefficient cell retention and lack of targeted 
localization that lead to cell death, thus limiting the effectiveness of the delivered 
cells [11-15].  
Recent research efforts have attempted to overcome these limitations by 
utilizing biomaterial for more efficient delivery of cells to the heart. Materials 
such as collagen, fibrin, gelatin, alginate, and Matrigel have been studied in this 
application in the form of injectable gels or three dimensional biomaterial 
scaffolds [16-22]. Many of these materials have shown potential for success; 
however they are not without their limitations. The issue of cell and material 
retention in injectable gels, as well as vascularization and nutrient diffusion 
through three-dimensional biomaterial scaffolds, remains a challenge [6, 16]. This 
illustrates the need for a biomaterial scaffold that will allow targeted, controlled 
delivery of stem cells to treat the patient, while maintaining cell viability. Here, 
we propose a novel scaffold and delivery method that will provide a matrix for 
cell attachment and growth, while anchoring cells during delivery. 
Recent work by Cornwell et al. has resulted in the formation of discrete 
fibrin microthreads [23]. Fibrin is a natural provisional matrix for cell attachment 
and migration during wound healing and has been used in the form of gels for 
cell delivery to infarcted myocardium [16, 17, 24]. These microthreads were 
developed for use as a scaffold leading to organized, aligned tissues and have 
been shown to support fibroblast attachment, proliferation and alignment [23]. 
Fibrin microthreads have the potential to overcome many of the limitations that 
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other scaffolds have encountered in cell delivery by providing a matrix for cell 
attachment and alleviating the potential for cells to wash out of the implant site. 
Their ability to be used in a manner similar to a suture is also advantageous, 
presenting a novel approach to scaffold delivery. By attaching the microthreads 
to a needle, the surgeon now possesses the ability to deliver stem cells to a 
precise location within the heart wall.  
In summary, we hypothesize that fibrin microthreads will support hMSC 
proliferation, survival and retention of differentiation capability, and may 
therefore facilitate targeted cell delivery to injured tissues such as infarcted 
myocardium.  In this way, we can directly treat the cause of the decline in cardiac 
function and restore contractile tissue within the infarcted area.  
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Chapter 2: Background 
This project investigates a novel method for stem cell delivery to infarcted 
myocardium. There are numerous aspects that need to be considered when 
researching a novel regenerative approach for any application. This work is a 
critical first step in exploring several fundamental questions regarding the 
overall feasibility of delivering human mesenchymal stem cells via a fibrin 
microthread scaffold. This section will present a brief review of cardiac anatomy 
and the implications of infarction as well as a summary of the current 
approaches to cardiac cell therapy and an overview of their limitations. 
2.1 Myocardial Infarction 
As the central pump for the circulatory system, the heart’s four chambers 
are repetitively filling with and expelling blood to deliver oxygen and nutrients 
to the rest of the body. The walls of the heart are principally muscular and 
thickest in the left ventricle where the highest pressures are reached. The heart 
muscle, or myocardium, is lined on either side by the endocardium and 
epicardium [25]. Gap junctions, coupling myocardial cells electrically, allow 
action potentials to propagate through the cell membranes and cause rhythmic 
contraction of all myocytes. Upon contraction, blood is forced out of the ventricle 
and into the aorta and coronary arteries, feeding the rest of the body and the 
heart muscle itself [26, 27].   
When a portion of the coronary circulation is blocked, blood supply to the 
myocardium is compromised and myocytes are starved of oxygen and nutrients. 
Within seconds, physiological and metabolic changes occur [28, 29]. Shortly after 
occlusion, adenosine triphosphate (ATP) production in the myocardium switches 
from an aerobic mechanism to an anaerobic mechanism. This happens as a result 
of oxygen and glucose deficiency in the tissue and causes the production of ATP 
to fall rapidly. Since the myocytes have less ATP to use for energy, the muscle 
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begins to lose its ability to contract. A short time later, the supply of creatine 
phosphate, which is used as an energy reserve for ATP production, is largely 
depleted. As anaerobic glycolysis continues, hydrogen ions accumulate as a 
byproduct and after several minutes the intracellular pH of the myocytes 
decreases [28]. This causes osmotic flooding of water into the myocytes. Edema 
occurs as the heart tissue continues to swell and irreversible damage and cell 
death occurs in the myocardium. Within weeks to months, scar formation takes 
place as fibroblasts infiltrate the infarct area and deposit fibrous collagen. 
Macrophages, monocytes, and neutrophils migrate to the infarcted area as part of 
the inflammatory response and matrix metalloproteinases (MMPs) released from 
the neutrophils causes further infarct expansion and myocyte collagen 
degradation [30].  
This process has been estimated to affect a billion cells in the heart, 
rendering them unable to contribute to the daily workload of the heart [11]. The 
American Heart Association estimates the economic cost of myocardial infarction 
and coronary heart diseases to be $156.4 billion. Myocardial infarction alone 
affects an estimated 920,000 people annually, and increases the chance of sudden 
death by four to six times that of the general population. Additionally, after an 
infarction, 22% of men and 46% of women are disabled by heart failure within six 
years. In this stage, the heart cannot pump enough blood to the body’s organs so 
patients are constantly tired and short of breath and thus cannot exert themselves 
in daily activities [31].  
2.2 Clinical Treatment for Myocardial Infarction 
Since the heart is unable to repair itself after infarction, medical 
intervention is necessary. If left untreated, the scarred region of dead tissue will 
thin and resulting in remodeling of left ventricular chamber dimensions [1]. The 
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ejection fraction, defined as the fraction of blood within the ventricle that is 
ejected with each stroke of the heart, declines with infarct size. However, 
compensatory responses work to maintain a normal stroke volume. Stroke 
volume is defined as the volume of blood ejected from the ventricle with each 
beat. This extra pressure and volume generated by the compensatory response 
causes stress in the ventricular wall to increase. This puts the ventricle at risk of 
aneurysm and rupture [1].  
Current medical interventions only treat the effects of infarction either by 
performing bypass surgery or reshaping the heart from the dilated, spherical 
shape, back to the original, efficient elliptical shape.  Coronary artery bypass 
grafting (or CABG) is typically done first to restore blood flow however this 
procedure does nothing to treat the infarct [32]. Alternatively, the use of surgical 
ventricular restoration has increased over the past 2.5 years in the United States 
as widespread clinical trials begin to prove its efficiency [33]. This is done using 
one of two procedures, direct linear closure or endocardial patch plasty [3].  
In direct linear closure, the infarcted myocardium is removed and the 
remaining heart tissue is sutured back together. This provides a method for 
restructuring the shape and size of the heart. However, there is not always 
enough myocardial tissue available to achieve the proper dimensions [4]. If the 
opening is larger than 3 cm an alternate surgery, called endoventricular patch 
plasty, is used which employs the use of a patch that is sutured in place of the 
excised infarct [2]. Specifically, the Dor procedure has been used since 1984 and 
requires the heart to be completely arrested. Coronary revascularization is 
performed to restore blood flow to the epicardial layer and preserve infarct 
thickness [32]. The infarcted region is cut out and a balloon is inflated within the 
left ventricle as a guide to restore the appropriate volume and shape for more 
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efficient heart function. A suture placed around the incision is used to tighten the 
ventricle to the shape of the balloon. Once the suture is tightened, a synthetic 
patch of polyethylene terephthalate (PET, also known as DacronTM) or 
polytetrafluoroethylene (PTFE) is used to close any remaining gap in the 
ventricular wall. The patch functions to restore the volume of the ventricle and 
prevent further distortion [2, 4]. 
While this surgical technique restores ventricular dimensions and 
maintains pressures within the heart, it does not facilitate the regeneration of 
new contractile tissue. The materials used in these procedures are inert, form 
large regions of fibrosis, and are typically 4 orders of magnitude stronger than 
native myocardium which produces a severe mismatch in mechanical properties 
[34].  Thus, the area continues to be a region of scarred tissue, not contributing to 
the overall work of the heart.   
2.3 Cellular Therapy: Cellular Cardiomyoplasty and Systemic Delivery 
Recent research efforts have focused on replacing dead myocardium with 
functional tissue in prevention of pathological ventricular remodeling. One 
method, cellular cardiomyoplasty also known as intramuscular injection, is 
defined as direct injection of cells into the myocardial wall, and aims to entrap a 
bolus of therapeutic cells within the vicinity of the infarct zone. Another method 
is systemic delivery which utilizes the circulatory system for a non-invasive 
method to repeatedly administer therapeutic cells via blood vessels. Both of these 
approaches focus on replacing the scarred, dead myocardium with viable cells 
[35, 36].  
Many different cell types have been utilized in these approaches including 
skeletal myoblasts, bone marrow stem cells, embryonic stem cells, resident 
cardiac stem cells and fetal cardiomyocytes [14, 36]. Skeletal myoblasts do not 
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electrically couple with the native myocardium and embryonic stem cells raise 
several political and ethical issues, as well as the potential for tumor formation. 
Much controversy still surrounds the existence of cardiac stem cells and fetal 
cardiomyocytes cannot be obtained in sufficient numbers to be an effective 
clinical treatment [14, 15, 36]. Thus, bone marrow stem cells, specifically human 
mesenchymal stem cells (hMSCs), have emerged as a promising cell type for 
cardiac repair.  
2.2.1 Human Mesenchymal Stem Cells in Cardiac Applications 
Isolated from adult bone marrow, hMSCs are a rare population of cells 
which represent only 0.001% to 0.01% of nucleated cells within the bone marrow 
[9, 37]. These cells are an adherent, multipotent population which possesses the 
ability to differentiate into tissues such as bone, cartilage and fat.  They are 
particularly attractive for use in regenerative therapy due to their relative ease of 
isolation, high expansion potential in-vitro, and genetic stability [9, 37, 38]. 
Specifically for myocardial regeneration, hMSCs have the unique characteristics 
to be used allogeneically without immune suppression, home to areas of injured 
tissue, induce increased angiogenesis, and have been shown to differentiate into 
a cardiomyocyte-like phenotype within the myocardium [8, 9, 14, 39, 40].  
Several research groups have investigated the effects of hMSCs on the 
post-infarcted heart and have reported many functional improvements as 
outlined in Table 1. This includes reduction of infarct size and improvements in 
ventricular performance [5-8, 40-44]. They have also demonstrated potential for 
myocyte differentiation and release of cytokines or growth factors that may 
stimulate repair mechanisms native to the myocardium [5-8, 41, 43, 44]. It is 
important to note that the mechanism by which cellular cardiomyoplasty and 
systemic delivery aid in functional cardiac improvements is highly controversial. 
Several different mechanisms have been proposed, including differentiation of 
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transplanted cells, passive presence of additional cells within the myocardial 
wall, cell fusion, and paracrine signaling [35, 44]. While the mechanism remains 
unknown, researchers agree that cellular therapy using hMSCs restores a 
significant portion of myocardial function and thus it remains a promising 
treatment.  
  
17 
 
Table 1: Outcomes of MSC use in cellular therapy 
Species 
# Cells 
Delivered 
Method of 
Delivery 
Functional Outcome Source 
Rat 1x107 Intramuscular injection 
-Decrease infarct size 
-Greater left ventricular wall thickness 
-Capillary density significantly higher 
-Cardiomyocyte-like differentiation of hMSCs 
[41] 
Rat 3x106 Intramuscular injection 
-LV systolic dysfunction attenuated 
-hMSCs expressed cardiac muscle proteins in the 
infarct 
-scar thinning was attenuated and microvessel 
formation increased 
[5] 
Rat 2x106 Intramuscular injection 
-Enhanced neovascularization 
-Increase in collagen and thickness preventing 
the scar thinning and expansion 
-Engrafted hMSCs stained positive for desmin 
-No evidence of synchronous contraction with 
native myocardium 
[6] 
Rat 2.5x106 or 5x106 Intramuscular injection 
-Effects are dose dependant, 5x106 MSCs nearly 
abolished the infarct area 
-Systolic performance improved to a level 
indistinguishable from sham animals 
-Improvement in diastolic function 
-Transplanted MSCs developed into cardiac 
myocyte-like cells  
[7] 
Rat 4x106 
Systemic (femoral vein, 
left ventricular infusion 
or right ventricular 
infusion) 
 
-All animals in right ventricular infusion group 
died of massive pulmonary emboli 
-Intravenous delivery is limited by entrapment 
of donor cells in the lungs 
-MSCs are preferentially attracted to and 
retained in ischemic tissue 
-Fewer than 1% of MSCs migrated to the 
myocardium after 4 hours 
[40] 
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Species 
# Cells 
Delivered 
Method of 
Delivery 
Functional Outcome Source 
Pig 
1x103 to 1x106per 
kg body weight 
Systemic (ear vein) 
-Stem cell treated animals had higher increase in body 
weight and heart weight 
-MSCs homed to areas of ischemia and showed dose 
dependant reduction of infarct size, improvement of 
ejection fraction, and hemodynamics at 1x105 and 
1x106 cells per kg body weight 
-MSCs were not detected in lung, liver or spleen, 
contrary to other similar studies 
[42] 
Pig 2x108 Intramuscular injection 
-Less than half of the implanted MSCs engrafted 
within the first 8 weeks 
-Decrease in infarct size and significant improvement 
in cardiac function 
-Myocardial efficiency increased to a normal level by 4 
weeks 
-Transplanted cells expressed proteins normally 
restricted to cardiac myocytes, vascular endothelium, 
and smooth muscle 
[44] 
Mouse 5x105 or 1x106 Intramuscular injection 
-Majority of delivered cells identified in the spleen, 
liver, and lungs 
-0.44% engraftment rate after 4 days 
-transplanted cells became morphologically 
indistinguishable from native myocardium and 
expressed desmin, β-myosin heavy chain, α-actinin, 
cardiac troponin T, and phospholamban 
-Observed sarcomeric organization of contractile 
proteins 
[8] 
Mouse 3x104 to 2x105 Intramuscular injection 
-New myocytes occupied more than half of the 
infarcted region, confirmed by cardiac specific staining 
(myocyte enhancer factor 2, cardiac specific 
transcription factor GATA-4, and the early marker of 
myocyte development Csx/Nkx2.5) 
-Transplanted cells appeared to differentiate to 
endothelial cells and smooth muscle cells 
-Reduction of infarct size and improvement in 
hemodynamics 
[10] 
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2.2.2 Limitations of Cellular Therapy 
While the literature outlined in Table 1 demonstrates the positive outcomes of 
cellular therapy, severe limitations exist. These limitations are inherent in the mode of 
delivery and include a lack of cell retention, localization, cell survival, and matrix for 
cell attachment leading to cell death [11, 13-15, 45].  
The injection of a bolus of cells into a muscular wall which is constantly 
contracting results in a large percentage of the freshly transplanted cells leaking back 
out the needle track and escaping the myocardial wall [11, 45]. Systemic delivery lacks 
targeted localization as well since a multitude of cells become entrapped in other major 
organs such as the lungs, liver, and spleen [40, 46]. Additionally since all cells were 
suspended in either phosphate buffered saline (PBS) or media, these cells lacked a 
matrix for cell attachment during delivery which also plays a role in their death [13, 15]. 
As a result of these limitations, less than 1 to 10% of cells actually engraft and 
survive within the myocardial wall [11, 36, 47]. With such significant losses in cell 
numbers, this brings forth the following question: how many cells ultimately need to be 
delivered to the myocardium to have a beneficial effect? Table 2 highlights key 
literature detailing the number of cells delivered and the respective engraftment rates 
that were observed. Current approaches deliver between 0.5x106 to 50x106 cells per 
heart [8, 13, 39, 40, 42, 43, 48]. Since the percent engraftment is reported, the actual 
number of cells that engraft in each study can be calculated from the total number of 
cells delivered. Also, this number of engrafted cells can be normalized to the rat heart 
since there are a variety of different species present and this is the animal model of 
concern for this project. Based on published weight measurements, the rat heart is about 
1% the size of a pig heart and 8 times the size of a mouse heart [49-53]. Thus, 400 to 
40,000 cells must be delivered to the rat myocardium in order to observe reductions in 
infarct size and improvements in ventricular performance.  
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Table 2: Engraftment rates for cellular therapy 
Species 
Number of Cells 
Delivered 
Engraftment 
Number of Cells 
Engrafted 
#  Cells Engrafted 
Normalized to Rat 
Source 
Mouse 5x105 0.44% 2,200 17,600 Toma, 2002 
Mouse 5x105 0.2% 1,000 8,000 Zhang, 2008 
Rat 4x106 < 1% <40,000 <40,000 
Barbash, 
2003 
Pig 50x106 0-6% <3x106 <36,900 
Freyman, 
2006 
Pig 
1x105 to 1x106 per 
kg bodyweight 
1-3% 
1,000-30,000 per kg 
bodyweight 
400-12,000 Wolf, 2008 
 
2.3 Biomaterials for Cardiac Regeneration 
The use of biomaterials presents an opportunity to overcome the limitations of 
cellular cardiomyoplasty and systemic delivery for more efficient delivery of cells to the 
heart. Biomaterials allow researchers to control the cellular microenvironment, and thus 
enable direction of cellular behavior [54]. Many factors must be taken into consideration 
when selecting and designing a biomaterial scaffold including properties such as 
scaffold degradation, porosity, compliance, size, and cell adhesion [15, 54, 55]. Materials 
such as collagen, gelatin, fibrin, and alginate, and Matrigel have been studied in cardiac 
applications as either injectable gels or three dimensional biomaterial constructs [16-22, 
48, 56-61].  
Alginate is a naturally derived polysaccharide from brown seaweed and has 
been used in the form of gels or three dimensional sponges for delivery of cells to 
infarcted myocardium [62]. Leor et at. used a cell seeded alginate sponge to create a 
bioengineered cardiac graft. This and other studies have demonstrated that alginate is 
favorable for tissue engineering constructs due to its hydrophilic nature, tunable 
porosity, extensive neovascularization in vivo, and biocompatibility [20, 62-64]. 
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However alginate is unable to specifically interact with mammalian cells due to its lack 
of arginine-glycine-aspartic acid (RGD) cell adhesion ligands, thus alginate is frequently 
covalently modified with this ligand [62]. Also, alginate is known to be mechanically 
unstable in vivo due to its ionic cross-linking and it undergoes slow uncontrolled 
dissolution [15, 65] 
Gelatin sponges are commercially available biomaterials made of purified 
porcine skin gelatin [66]. Studies by Akhyari et al. and Li et al. used gelatin sponges for 
culture and delivery of cells to the myocardium. This material is biodegradable and 
supports the attachment and spontaneous contraction of cultured cells. However, this 
scaffold is too porous and naturally thrombogenic to be used in blood contacting 
applications [61, 66, 67]. 
Matrigel is a liquid basement membrane extract of collagen, proteoglycans, and 
laminins that consolidates to gel consistency after a few hours at 37°C [22]. Studies have 
shown that it is angiogenic largely due to its growth factor contents, it can assume the 
geometry of the host environment, and in combination with collagen gel, it supports 
injection of cells for improvements in cardiac function [19, 21, 22, 57]. However, due to 
its consistency, it is not ideal for use alone or as a scaffold that promotes in situ 
regeneration [15].  
Collagen is the main component of connective tissues and is the most abundant 
protein in mammals. Its use in cardiac applications, either as a three dimensional 
sponge or as a gel, has shown its support of cells for delivery and spontaneous 
contraction [60, 68, 69]. Collagen is hydrophilic, degradable and an excellent substrate 
for cell attachment and infiltration. However it can have poor mechanical properties, 
lack structural stability, exhibit a large degree of swelling in culture medium, and is 
weakly immunogenic and thrombogenic [58, 70].  
Christman et al. were the first to demonstrate the improvement in cell survival 
when using an injectable fibrin scaffold as compared to intramuscular injection of a cell 
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suspension [15]. Fibrin is a natural provisional matrix for cell attachment and migration 
during wound healing. A complex series of coagulation reactions, triggered by platelet 
adherence after injury, leads to the production of thrombin. This enzyme cleaves 
fibrinogen, which is naturally circulating in the blood, and forms a complex, 
interwoven, fibrin clot to stop bleeding and encourage healing [71, 72]. These two 
components, fibrinogen and thrombin, are used commercially to mimic this final stage 
in the coagulation cascade as surgical fibrin sealants and fibrin gels for tissue 
engineering [24].  The natural presence of RGD binding motifs to facilitate cell adhesion, 
the possibility of using autologous fibrinogen and thrombin, the natural presence of 
growth factors, its Food and Drug Administration (FDA) approval for clinical use, and 
its angiogenic characteristics make fibrin attractive for cardiac applications [16, 56, 73].  
While all these materials have shown potential for increasing cell survival, the 
issue of cell and material retention in injectable gels continues to remain a challenge [16, 
24, 48]. Additionally, the three-dimensional biomaterial constructs meant to be full 
thickness patches for infarct regeneration are plagued by problems with vascularization 
and nutrient diffusion [6, 16]. These patches are typically on the order of several 
millimeters in thickness while diffusion can only supply nutrients to a depth of 150μm 
[11]. This is not suitable for keeping the entire construct viable while vascularization is 
taking place in vivo. This illustrates the need for design of a biomaterial scaffold to 
facilitate targeted, controlled delivery of stem cells to the myocardial wall, while 
allowing stem cell growth and maintaining cell viability. This scaffold should induce 
angiogenesis for new blood vessel formation and persist long enough to guide the 
integration of cells, but not so long as to interfere with cell coupling essential to 
myocardial function [54]. The ability to deliver growth factors via this scaffold is a 
desirable capability as well, since growth factors can be used to direct many cellular 
processes.  
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2.3.1 Fibrin Microthreads 
Discrete fibrin microthreads have recently been developed by Cornwell et al. as a 
novel scaffold to direct cell orientation and migration for tissue regeneration. These 
microthreads are attractive as tissue engineering scaffolds due to their combination of 
cell signaling and structural properties [23]. Evaluation by Cornwell et al. demonstrated 
that fibrin microthreads were significantly higher in tensile strength than fibrin gels and 
proved their support of fibroblast viability, alignment, growth, and migration for 7 days 
in culture. These fibrin microthreads are able to be crosslinked for increased tensile 
strength and stiffness, and can be loaded with growth factors to influence cellular 
processes [23, 74].  
Here, we propose to use fibrin microthreads as a matrix for cell attachment to 
anchor cells during delivery. Fibrin has been shown to support hMSC viability and 
growth in the form of a gel [16, 17, 24]. Fibrin is angiogenic, biodegradable and the 
microthreads are capable of being loaded with growth factors. Also their structural 
properties present the opportunity for the microthreads to be used in a manner similar 
to a suture is also advantageous, presenting a novel approach to scaffold delivery. By 
attaching the microthreads to a needle, the surgeon now possesses the ability to deliver 
the stem cells to a precise location within the heart wall. 
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Chapter 3: Hypothesis and Specific Aims 
We hypothesize that fibrin microthreads will support hMSC proliferation, 
survival, and retention of differentiation capability and may therefore facilitate targeted 
hMSC delivery to injured tissues such as infarcted myocardium.  Specifically, 
quantification of the number of cells will verify that the microthreads are capable of 
delivering between 400 and 40,000 hMSCs and immunohistochemistry and functional 
differentiation assays will confirm cell viability, proliferation, and retention of 
multipotency. 
Specific Aim 1: Quantify cell number on fibrin microthreads 
Here we hypothesize that fibrin microthreads are capable of supporting between 
400 and 40,000 hMSCs. To test this we bundled individual fibrin microthreads in groups 
of 4 and seeded them with hMSCs. After 1, 3, and 5 days in culture, microthreads were 
analyzed by two methods. For the first method, microthreads were removed from 
culture and stained with Hoechst dye to visualize nuclei. The number of nuclei per area 
of microthread was counted using ImageJ software. For the second method we sought 
to develop a reproducible, time efficient assay for cell quantification to improve upon 
the limitations of counting Hoechst dye stained nuclei. Microthreads were digested in 
trypsin and hMSCs were re-plated in a standard tissue culture plate. The CyQuant 
Cellular Proliferation Assay was used to quantify cell number by converting 
fluorescence intensity, produced by a cyanine dye binding to cellular DNA, to cell 
number via a standard curve.  
Specific Aim 2: Confirm hMSC viability and proliferation on fibrin microthreads 
Here we hypothesize that fibrin microthreads support the viability and 
proliferation of hMSCs. Human mesenchymal stem cells seeded on fibrin microthread 
bundles for 1, 3, and 5 days were stained with Ki-67, a protein present in the nuclei of 
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proliferating cells. The number of Ki-67 positive cells was counted and a percentage of 
Ki-67 expression was calculated relative to the total number of cells present. To 
investigate the effect of fibrin on hMSC proliferation Ki-67 expression on microthreads 
was also compared to Ki-67 expression of hMSCs cultured on standard and fibrin 
coated chamber slides. Cell viability was determined using the LIVE/DEAD assay.  
Specific Aim 3: Demonstrate hMSC retention of multipotency 
Finally, we hypothesize that hMSCs will retain their ability to differentiate after 
being cultured on fibrin microthreads. Fibrin microthread bundles seeded with hMSCs 
were cultured for 5 days. At the conclusion of culture time the bundles were digested 
with trypsin, re-plated in a standard tissue culture plate, and exposed to standard 
differentiation protocols for adipogenesis and osteogenesis. Adipogenic cultures were 
stained for the presence of lipid vacuoles using Oil Red O and osteogenic cultures were 
evaluated for calcium deposition via Alizarin Red S staining.  
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Chapter 4: Materials and Methods 
This section details the procedures used to achieve our specific aims. Fibrin 
microthread production and seeding of hMSCs will be described, as well as our 
methods of analysis for quantification of cell number, proliferation, viability, and 
differentiation.  
4.1 Fibrin Microthread Production and Seeding 
Fibrin microthreads were produced according to a previously published protocol 
[23]. Briefly, fibrinogen and thrombin from bovine plasma (Sigma Aldrich, St. Louis, 
MO) were placed into separate 1 mL syringes. The solutions were combined by a 
blending applicator tip (Micromedics, St. Paul, MN) and extruded through 
polyethlyene tubing (0.38mm inner diameter, Beckton Dickinson, Franklin Lakes, NJ) 
into a bath of 10mM HEPES, pH 7.4 at room temperature (Figure 1). After 15 minutes, 
the microthreads were removed from the bath and hung to dry overnight. This process 
produced individual fibrin microthreads with an average hydrated diameter of 100 um 
[23].  
 
Figure 1: Fibrin microthread extrusion process [23] 
In order to facilitate cell attachment, the individual microthreads were grouped 
together to form a bundle of fibrin microthreads. Specifically, bundles of microthreads 
were formed by placing four microthreads adjacent to each other and dragging a 
droplet of phosphate buffered saline (PBS) along the length of the microthreads until 
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they adhered to each other (Figure 2). This provided grooves for initial cell attachment 
and increased surface area for cell growth as compared to a single large diameter 
microthread.  
 
 
Figure 2: Microthread bundling procedure 
To prepare microthreads for seeding, bundles were glued to 3.0 cm outer 
diameter stainless steel washers (Seastrom Manufacturing, Twin Falls, ID) with Silastic 
Silicone Medical Adhesive Type A (Dow Corning, Midland, MI). Individual washers 
were placed in wells of a standard 6-well plate over a 13 mm diameter circular 
ThermanoxTM coverslip (Nalge Nunc International, Rochester, NY) as seen in Figure 3. 
Prior to seeding, the washers with attached bundles were rehydrated with PBS for 15 
minutes, then sterilized using 70% isopropyl alcohol for 1 hour, rinsed with three 
washes in sterile PBS for 15 minutes, and air dried in a laminar flow hood overnight.  
Microthreads 
Forceps 
Tape 
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Figure 3: Microthread/washer diagram 
Microthread bundles were seeded with hMSCs according to standard cell culture 
procedures. Human mesenchymal stem cells (Lonza, Walkersville, MD) in culture were 
trypsinized, centrifuged, and re-suspended at a concentration of 500,000 cells/mL in 
Mesenchymal Stem Cell Growth Medium (MSCGM: 10% mesenchymal stem cell 
growth supplement, 2% L-glutamine, 0.1% gentamicin sulfate/amphotericin-B in 
mesenchymal stem cell basal medium, Lonza, Walkersville, MD). Passage 4-9 hMSCs 
were used for all experiments. A 100 μL drop of cell suspension was placed in the 
center of the coverslip and the plate was placed in a 370 C, 5% CO2 incubator. After 2 
hours of incubation, the washers with attached microthreads were rinsed with PBS to 
remove unattached cells and transferred to new 6-well plates containing 2 mL of fresh 
media, changed every three days (Figure 4).  
 
Figure 4: Microthread/washer culture 
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4.2 Quantification of Cell Number 
The procedures described here focus on quantifying the number of cells that can 
be delivered to the target location using fibrin microthread bundles. Initially, 
microthreads were seeded with hMSCs and counterstained with Hoechst dye to 
determine cell density by counting. While this method allows quantification of cell 
number it has several limitations that restrict the efficacy of the results. Thus we sought 
to develop a quantitative assay for assessment of cell number to overcome these 
limitations. 
4.2.1 Estimation of Cell Attachment 
An approximation of cell attachment on fibrin microthreads can be obtained by 
calculating the surface area available for cell attachment on a microthread bundle and 
dividing it by the average area of an hMSC. In this way, we can obtain an estimate of 
how many hMSCs can theoretically be cultured on a bundle of fibrin microthreads.  
 The surface area of a bundle of four microthreads was calculated by first 
approximating the circumference of the microthread bundle and multiplying it by the 
microthread length. Based on Figure 5, about 75% of an individual microthread 
circumference is exposed for cell attachment. Therefore, the circumference of a bundle 
of 4 microthreads is as follows:  
 
Where d1 is the diameter of a single microthread (100 um), α is the approximate 
percentage of individual microthread exposed for cell attachment in the bundle (0.75), 
and β is the number of microthreads in the bundle (4). The total surface area was then 
determined by multiplying the bundle circumference by the length of the microthread 
bundle.  
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Figure 5: Microthread bundle circumference 
 Average hMSC area was calculated based on a phalloidin stained image of 
hMSCs cultured on an 8-well chamber slide (Nalge Nunc International, Rochester, NY). 
Using ImageJ software (National Institutes of Health, Bethesda, MD), the freehand 
sections tool was used to trace the perimeter of twenty cells and the measure function 
was used to determine the area within the trace. The number of cells per microthread 
was calculated by dividing the total surface area of the microthread bundle by the 
average area of an hMSC (1,255 + 911 um2).  
4.2.2 Quantification of Cell Number via Hoechst Dye Staining  
Microthread bundles were seeded as previously described. After 5h, 1, 2, 3, 4, 
and 5 days in culture, washers with attached microthread bundles were removed from 
the 6-well plate and rinsed with PBS. The microthreads were cut from the washers, 
placed on glass slides, fixed in 4% paraformaldehyde in PBS (Boston Bioproducts, 
Worcester, MA) for 10 minutes, rinsed with two washes of PBS for 5 minutes each, and 
then permeabilized with 0.25% Triton-X100 in PBS for 10 minutes. Then microthreads 
were blocked with 1% bovine serum albumin in PBS for 10 minutes and stained with 
Alexa Fluor 488 conjugated phalloidin (5μL stock solution in 200μL PBS, Invitrogen 
A12379, Carlsbad, CA) for 30 minutes to illuminate the f-actin filaments in the 
cytoskeleton. Microthreads were then rinsed with three washes of 1% bovine serum 
albumin in PBS for 10 minutes each and counterstained with Hoechst dye (Cambrex Bio 
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Science, Charles City, IO) at a concentration of 1:6000 for 5 minutes to visualize cell 
nuclei.  
Cell density was determined by counting the number of cells per square 
millimeter of microthread from fluorescent images taken with a Leica DM LB2 
microscope. A total of six microthread bundles from two separate experiments were 
imaged per time point under 10x magnification. Images were taken successively along 
the cell populated region of the microthreads until the entire length was viewed, this 
required anywhere from 5 to 13 images. Counts and area measurements were 
performed using Image J software with the Cell Counter plug-in. Raw data was 
reported as the number of cells per square millimeter of microthread bundle.  
In order to compare the results from this quantification method to alternate 
quantification methods and results from literature, the total number of cells per 
microthread bundle needed to be calculated. The total number of cells per microthread 
bundle can be extrapolated from the raw data by using the bundle surface area 
calculation from Section 4.2.1 and multiplying by the number of cells/mm2 counted. 
Adjustments for the unseeded ends of the microthread bundle, as seen in Figure 6, were 
made by measuring the unseeded area of three microthreads at each time point.  The 
average unseeded area was then subtracted from the total surface area of the 
microthread bundle, to yield the average cell populated area of microthread. This 
adjustment was necessary in order to account for the tail portions of the microthread 
that were not populated by cells, otherwise simple multiplication of the entire surface 
area of the microthread bundle by cell density would overestimate cell number. This 
type of data manipulation is by no means an ideal method for determining total cell 
number on the microthread bundle since it calculates the surface area of a three 
dimensional sample based on a two dimensional image. It is meant only to serve an 
approximation of total cell number for comparative purposes.  
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Figure 6: Diagram of hMSCs on microthread bundle 
4.2.3 CyQuant Cellular Proliferation Assay 
 While counting Hoechst dye stained nuclei allows quantification of cell number 
it has several limitations. First, it is very time consuming to count individual nuclei on 
microthread bundles which effectively limits sample size. Second, since we are limited 
to imaging this three dimensional scaffold in a single plane, not all the cells on the 
microthread are able to be counted. Finally, the amount of microthread area visible in 
images varies due to the placement of the microthread on the slide and flattening by the 
coverslip. Thus, all counts of nuclei must be normalized to the viewable surface area.  
To overcome these limitations we sought to develop an automated assay for 
more reproducible, quantitative, and high throughput analysis. Based on the cell count 
from the Hoechst dye protocol, we determined that the assay must detect as few as 
1,000 cells and up to 20,000 cells. Product research revealed that the CyQuant Cellular 
Proliferation Assay (Invitrogen, Carlsbad, CA) had the appropriate sensitivity. This 
assay employs a cyanine dye that fluoresces upon binding to double stranded DNA and 
can detect as few as 50 cells [75, 76]. This dye has been proven to correlate well with 
measurements made using [3H]-thymidine, which in turn has been shown to be 
equivalent to the Hoechst 33342 fluorochrome [75, 77].  
 First, to determine dye incubation time, hMSCs were passaged according to 
standard cell culture protocols and plated in a 96-well plate (Beckton Dickinson, 
Franklin Lakes, NJ) at concentrations of 100 to 50,000 cells per well in 100 μL of 
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CyQuant dye prepared as per kit protocol. The dye was allowed to incubate with the 
cells in a 370 C, 5% CO2 incubator and a reading was taken with a Victor3 1420 
Multilabel Counter every ten minutes from 30 minutes to 80 minutes. Wells with dye 
alone served as controls for background fluorescence subtraction. Fluorescent intensity 
was plotted versus time for each cell concentration. The appropriate dye incubation 
time was determined as the time after which fluorescence intensity does not statistically 
change with time.  
Cell attachment to microthreads was quantified using the CyQuant assay at 1, 3, 
and 5 days in culture. The diagram in Figure 7 depicts the procedure. Microthreads 
were cut from the stainless steel washers and digested in 0.5 mL of 0.25% trypsin in 
Hank’s Balanced Salt Solution (Invitrogen, Carlsbad, CA) at 370 C for 5 minutes. An 
equivalent amount of MSCGM was added to inactivate the trypsin and the suspension 
was centrifuged for 5 minutes at 1,000 RPM. The supernatant was removed by pipetting 
and the pellet was re-suspended in 200 μL of fresh media and transferred to wells of a 
96-well plate. The plate was placed in a 370 C, 5% CO2 incubator for 4 hours to allow 
complete cell attachment. Each well was then rinsed with 200 μL of sterile PBS twice to 
remove residual thread debris. CyQuant dye (100 μL per well) was added to the plate 
and it was returned to incubation. After one hour, a reading was taken with the Victor3 
1420 Multilabel Counter to measure fluorescence intensity and cell number was 
calculated based via a standard curve. Unseeded threads and hMSCs plated at 1,000 
cells per well served as controls.  Background fluorescence was measured by way of 
wells with CyQuant dye alone.  
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Figure 7: CyQuant procedure 
To correlate fluorescence intensity with cell number, a standard curve was 
created. Human mesenchymal stem cells were passaged and seeded at 100 to 50,000 
cells per well in a 96-well plate. Cells were allowed to attach overnight and then were 
processed in the same manner as the microthreads. By creating the standard curve in 
this way, we ensured that the cells were exposed to the same conditions and thus 
accounted for any loss of cells due to the assay procedure. Wells with CyQuant dye 
alone were used to measure background fluorescence of the dye. The standard curve 
was created by subtracting the background fluorescence from the fluorescence intensity 
of each cell concentration and plotting known cell number versus fluorescence. A linear 
trend line was fit to the graph and R-squared value and slope were determined.   
4.3 Cell Proliferation 
 To confirm that the increase in cell number over time in culture on fibrin 
microthreads is due to cellular proliferation, microthreads were fixed and stained with 
an antibody against Ki-67. Ki-67 is a protein expressed during G1, S, G2, and M phases 
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of the cell cycle. The white arrows in Figure 8 show Ki-67 positive nuclei. Microthread 
bundles were seeded with hMSCs as described previously. At 1, 3, and 5 days bundles 
were removed from the washers, rinsed in PBS and placed on glass slides. Microthreads 
were fixed with 4% paraformaldehyde in PBS for 15 minutes, rinsed in PBS for 5 
minutes, and permeabilized with 0.25% Triton-X100 in PBS for 10 minutes. Following 
two rinses in PBS for 5 minutes each, microthreads were exposed to epitope retrieval for 
40 minutes in 10% Dako Cytomation Target Retrieval Solution, pH 9 (S2367, Dako, 
Carpinteria, CA) in diH2O and allowed to cool for 20 minutes. Microthreads were then 
rinsed twice with PBS for 5 minutes each and then blocked with 5% normal rabbit 
serum in PBS for 30 minutes. Next microthreads were incubated in a 1:100 dilution of 
Ki-67 mouse IgG1 (sc-23900 Santa Cruz Biotechnology Inc, Santa Cruz, CA) in 5% 
normal rabbit serum for 1 hour, rinsed with three washes of PBS for 5 minutes each, and 
then incubated with a 1:200 dilution of Alexa 488 rabbit anti mouse IgG (A11059 
Invitrogen, Carlsbad, CA) in 5% rabbit serum for 1 hour.  Following three rinses in PBS 
for 5 minutes, microthreads were counterstained with Hoechst dye at a concentration of 
1:6000 for 5 minutes (Cambrex Bio Science, Charles City, IO) to visualize cell nuclei. 
Seeded microthreads incubated in a 1:100 dilution of mouse IgG (I-2000 Vector Labs, 
Burlingame, CA) in place of the Ki-67 primary and unseeded threads stained with both 
the Ki-67 primary and secondary served as negative controls. Fluorescent images were 
captured with Leica DM LB2 microscope from four bundles stained in two separate 
experiments. Images were taken randomly along the cell populated region of 
microthread. From these, ten images were randomly selected and the percentage of cells 
in the cell cycle was calculated by counting the number of Ki-67 positive cells and 
dividing that by the total number of cells per image.  
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Hoechst Dye Ki-67 Overlay 
   
Figure 8: hMSCs labeled with Ki-67 
Typical doubling time for low passage (P2-10) hMSCs in culture is 5 to 7 days 
[78]. Looking at the data from Hoechst dye counts, hMSCs appear to be proliferating 
much faster, increasing 7-fold over 5 days. To investigate if fibrin had an effect on 
hMSC proliferation we compared hMSC proliferation on normal tissue culture surface 
to hMSC proliferation on a fibrin coated surface. Fibrin gels, consisting of the same 
components as the microthreads, were formed by spreading 48.6 μL of 35 mg/mL 
fibrinogen in the bottom of an 8-well chamber slide (Nalge Nunc International, 
Rochester, NY) using a shaker plate [79, 80]. After 5 minutes the shaker plate was 
turned off, 48.6 μL of 6 U/mL thrombin was added to each well, and the shaker plate 
turned back on. After 15 minutes, the slides were transferred 40 C and left overnight to 
allow gel formation. To form a thin fibrin coating, the slides were removed from 40 C 
and allowed to dry overnight in a desiccator.  Each well was then rinsed two times in 
10mM HEPES buffer for 5 minutes, sterilized in the same manner as the fibrin 
microthreads, and allowed to dry overnight in a laminar flow hood. Presence of a fibrin 
coating was assessed by trypan blue staining and light microscopy. 
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Figure 9: Fibrin coated chamber slide  
Human mesenchymal stem cells were seeded in fibrin coated 8-well chamber 
slides (200μL of 10,000 cells/mL) following standard cell culture practices. After 1, 3, 
and 5 days, the 8-well chamber slides were stained with Ki-67 as described previously. 
Human mesenchymal stem cells cultured on normal tissue culture treated 8-well 
chamber slides at the same density served as a comparison. Percentage of cells in the 
cell cycle was calculated by counting the number of Ki-67 positive cells and dividing 
that by the total number of cells per image. Ten images (20x magnification) were 
randomly selected from four chambers of two slides stained in two separate 
experiments.  
4.4 Cell Viability 
In order to confirm viability of hMSCs cultured on microthreads, the hMSC 
seeded bundles were exposed to LIVE/DEAD Viability/Cytoxicity Kit for mammalian 
cells (Invitrogen L-3244, Carlsbad, CA). This is a dual component stain, calcein enters 
the cytoplasm of live cells and upon conversion by intracellular esterase activity, 
fluoresces green. Ethidium enters the nuclei of dead cells and fluoresces red upon 
binding to nucleic acids. This experiment was done by preparing and seeding 
microthread bundles as described previously. After 5 days in culture, the microthread 
bundles were cut from the washers, rinsed in PBS, and placed on a glass slide to 
incubate in 8 μM ethidum, 4 μM calcein in PBS for 30 minutes. Fluorescent images were 
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captured with a Leica DM LB2 microscope at 20x magnification of two slides stained in 
two separate experiments. Controls were prepared by incubating hMSCs in 30% 
methanol for 30 minutes to prove that any green fluorescence seen was a result of live 
cells and not autofluorescence of the microthread bundle. 
4.5 Differentiation 
 As with all multipotent stem cells, hMSCs are able to differentiate into a variety 
of cell types. To confirm that hMSCs maintain their multipotency after culture on fibrin 
microthreads, cells were exposed to standard differentiation protocols using an 
adipogenic kit available from Lonza (Adipogenic Differentiation Medium, PT-3004) and 
an osteogenic kit from Invitrogen (StemPro Osteogenesis Differentiation Kit, A10072-
01). Mesenchymal stem cells that had not been cultured on threads served as positive 
and negative controls.  
 Microthreads were bundled, sterilized, seeded, and cultured for 5 days. At the 
conclusion of time in culture microthread bundles were digested in 0.5 mL of 0.25% 
trypsin in Hank’s Balanced Salt Solution (Invitrogen, Carlsbad, CA) at 370 C for 5 
minutes. An equivalent amount of MSCGM was added to inactivate the trypsin and the 
suspension was centrifuged for 5 minutes at 1,000 RPM. For adipogenic differentiation, 
cells were re-suspended and re-plated at 2.1 x 104 cells per cm2 tissue culture surface 
area and fed every 2–3 days with MSCGM until cultures reached 100% confluence, 
approximately 5–13 days. Cells were then fed for three cycles of 3 days with Adipogenic 
Induction Medium followed by 1–3 days with Adipogenic Maintenance Medium. 
Negative control hMSCs were fed with Adipogenic Maintenance Medium only. After 
the three cycles, all cells were cultured for an additional week in Adipogenic 
Maintenance Medium. At the end of each week cells were analyzed using light 
microscopy for characteristic lipid vacuole formation as seen in Figure 10. At the 
conclusion of the feeding cycle adipogenic cultures were stained with Oil Red O to 
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assess lipid vacuole formation. Cultures were fixed in 4% paraformaldehyde in PBS for 
15 minutes, rinsed in distilled water for 5 minutes and dehydrated in 60% isopropanol 
for 5 minutes. An Oil Red O stock solution was made by dissolving 300 mg of Oil Red 
powder (MP Biomedical, Solon, OH) in 100 mL of 100% isopropanol. Oil Red O 
working solution was made by combining 3 parts stock solution with 2 parts distilled 
water in distilled water and then passed through a syringe filter (0.80μm membrane, 
Corning Incorporated, Corning, NY). Cultures were stained with Oil Red O working 
solution for 10 minutes and then rinsed in 60% isopropanol for 5 minutes, and distilled 
water for 5 minutes. Cells were counterstained with Mayer’s hematoxylin (Sigma 
Aldrich, St. Louis, MO) for 1 minute, rinsed with distilled water, and viewed under a 
light microscope. 
  
Figure 10: Osteogenic (left) and adipogenic (right) cultures 
For osteogenic differentiation, cells were re-suspended and re-plated at 5 x 103 
cells per cm2 tissue culture surface area and cultured overnight in MSCGM. Cells were 
then fed with Complete Osteogenesis Differentiation Medium which was replaced 
every 3–4 days for 2–3 weeks. Negative control cells were fed with MSCGM on the 
same schedule. At the end of each week cells were analyzed using light microscopy for 
characteristic cobblestone appearance. At the conclusion of the feeding schedule, cells 
were stained with Alizarin Red S to assess calcium deposition, as seen in Figure 10. 
Cells were removed from culture, rinsed in PBS containing calcium and magnesium 
(Invitrogen, Carlsbad, CA) for 1 minute and fixed in 4% paraformaldehyde in PBS for 
15 minutes. Cultures were then rinsed with one wash of PBS containing calcium and 
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magnesium for 5 minutes followed by one wash of distilled water 5 minutes. Alizarin 
Red S stock solution was made by dissolving 2 grams of Alizarin Red powder in 100 mL 
distilled water and adjusting pH to 4.1-4.3 with 10% ammonium hydroxide. Cells were 
stained with Alizarin Red S working solution for 5 minutes, then rinsed three times 
with distilled water for 5 minutes each, and viewed under a light microscope.  
4.6 Statistics 
Statistical comparisons were carried out using SigmaStat 3.1 (Systat Software, 
Inc., Point Richmond, CA). Statistical difference between two groups was analyzed 
using Student’s T-test or the Mann Whitney Rank Sum test for cases of unequal 
variance. Statistical difference between groups was analyzed using ANOVA with 
Holm-Sidak post hoc testing. In cases where data failed the normality test an ANOVA 
on Ranks followed by a Tukey post hoc test was used since data was not transformed to 
accommodate the non normality. Significance was established for p < 0.05. All 
experiments were repeated to a minimum of n = 2.   
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Chapter 5: Results 
5.1 Quantification of Cell Number  
The estimated number of cells that we hypothesize could feasibly attach to a 
fibrin microthread bundle is shown in Table 3. Detailed measurements for hMSC area 
can be found in Appendix A. The grooves created by bundling 4 individual 100 um 
microthreads together increases surface area for cell attachment by about 50% as 
compared to a single, 200 um diameter microthread. The number of cells expected to 
attach to a bundle of 4 microthreads is approximately 15,000 cells per 2 cm length of 
thread.  
Table 3: Theoretical cell attachment calculations 
Parameter Bundle of 4 Large diameter thread 
Microthread Diameter (um) 100 200 
Microthread Circumference (um) 314 628 
Circumference Available 0.75 1 
Number of Microthreads 4 1 
Microthread Length (cm) 2 2 
Microthread Surface Area (mm2) 18.8 12.6 
hMSC Area (um2) 1,255 1,255 
hMSC/2cm Microthread 15,008 10,005 
 
5.1.1 Quantification of Cell Number via Hoechst Dye Staining 
 Hoechst dye and phalloidin stained images are shown in Figure 11. The Hoechst 
dye images show a clear increase in cell number from day 1 through day 5. Cells appear 
to settle in the grooves of the thread bundle at day 1, then proceed to spread out and 
cover the entire surface of the microthreads by day 5. Phalloidin staining shows that the 
hMSCs appear to align with the long axis of the microthread as compared to their 
random orientation on a chamber slide, however this was not quantitatively evaluated.  
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Figure 11: Hoechst dye and phalloidin images of microthread bundles 
43 
 
The density of cells attached to a bundle of 4 microthreads as determined by 
visual counting is shown in Figure 12 and Table 4. There was a statistically significant 
increase in cell number by days 4 and 5, reaching 731 + 101 cells/mm2 after 5 days (the 
latest time point evaluated). Raw data including counts, area measurements, and 
statistics can be found in Appendix B.  
Table 4: Average number of cells/mm2 on microthread bundles (n = 6) 
Time Point Average #cells/mm2+ SEM 
5 hours 93 + 21 
1 day 253 + 57 
2 day 315 + 84 
3 day 555 + 49 
4 day 616 + 83 
5 day 731 + 101 
 
 
(* indicates statistically significant difference between 5 hour, 1 day and 3, 4, 5 day for p<0.05, there is no statistical difference 
between 5 hour and 1 day as well as between 3, 4, and 5 days; † between 2 day and 4, 5 day for p<0.05, there is no statistical 
difference between 4 day and 5 day) 
Figure 12: Cells/mm2 of microthread bundle (n = 6) 
* 
† 
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In order to compare the results from this quantification method to alternate 
quantification methods and results from literature the total number of cells per 
microthread bundle was calculated. From the calculations in Table 3, the surface area of 
a microthread bundle is 18.8 mm2. Since the tail ends of the microthread bundle are not 
populated with cells, the average unpopulated area (5.6 + 1.1 mm2) was subtracted from 
the surface area of the bundle (18.8 mm2) before multiplying by the cell density from 
Table 4. This adjustment was necessary in order to account for the tail portions of the 
microthread that were not populated by cells, otherwise simple multiplication of the 
entire surface area of the microthread bundle by cell density would overestimate cell 
number. The data in Table 5 and Figure 13 shows the total number of cells on the 
microthread bundle. Based on these calculations the microthread bundles support 
approximately 10,000 hMSCs at 5 days in culture. Raw data from these calculations can 
be found in Appendix C. 
Table 5: Total number of cells per microthread bundle 
Time Point Average #cells/bundle + SEM 
5 hours 1,225 + 272 
1 day 3,344 + 755 
2 day 4,169 + 1,109 
3 day 7,320 + 652 
4 day 8,125 + 1,097 
5 day 9,644 + 1,339 
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Figure 13: Cells per microthread bundle 
5.1.2 CyQuant Cellular Proliferation Assay 
To overcome the limitations encountered by quantifying cell number on 
microthreads via Hoechst dye counts, we attempted to develop an assay for more 
reproducible, high throughput analysis. The standard curve for the CyQuant assay is 
shown in Figure 15. It can be fit with a linear trend line with R2 value approaching 1 (R2 
= 0.9845). Statistics indicate the curve is sensitive enough to detect as few as 100 cells. 
Graphing fluorescence intensity versus time shows that after 50 minutes of dye 
incubation there is no statistical change in intensity with time. Thus, all CyQuant 
experiments were allowed to incubate for 60 minutes. Raw data and statistics can be 
found in Appendix E. 
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Figure 14: CyQuant standard curve, microthreads (n = 5) 
 Analysis of the supernatant from centrifugation and the PBS from rinses showed 
minimal cell loss. This indicates that neither of these steps is causing significant 
numbers of cells to be lost from the assay. Additionally, statistics indicate that there was 
no difference between the thread control group and the blank wells (Figure 17). Figure 
15 shows a representative image of thread debris in a thread control well before rinsing. 
Figure 16 shows a thread control well after rinsing, largely free of any debris. This 
indicates that any fluorescent intensity measured after background subtraction is a 
result of cells and not remnants of microthread left after digestion. Raw data can be 
found in Appendix F. 
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Figure 15: Thread control well before rinsing 
 
Figure 16: Thread control well after rinsing 
 
 
Figure 17: Comparison of thread control well to blank well (n = 24) 
The number of hMSCs per microthread bundle measured by the CyQuant assay 
is summarized in Figure 18 and Table 6. Only microthread bundles at 5 days showed a 
statistically significant increase in cell number (p < 0.05), reaching an average of 4,000 
cells per bundle. This is significantly less than the number of cells found by Hoechst dye 
counts (Figure 13 and Table 5). Raw data can be found in Appendix G.  
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Table 6: CyQuant - number of cells per bundle (n = 12) 
Time Point Average # cells/bundle+ standard deviation 
1 Day 1,588 + 608 
3 Day 1,652 + 704 
5 Day 4,016 + 3,346 
 
 
(* indicate statistically significant difference between 1, 3 days and 5 days for p<0.05, there is no statistical difference between 1 and 
3 days) 
Figure 18: CyQuant - number of cells per bundle (n = 12) 
  
5.2 Cellular Viability and Proliferation 
The results of the LIVE/DEAD assay are shown in Figure 19. The first column 
depicts the calcein which turns the cytoplasm of live cells green. The second column 
depicts the ethidium which turns the nuclei of dead cells red. The third column is the 
overlay of the previous two images. This demonstrates that cells were viable after 5 
days in culture on microthread bundles with minimal cell death (dead cells indicated by 
* 
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white arrows). The control (hMSCs fixed in 30% methanol) proved that all green 
fluorescence seen on the microthread bundle was due to live hMSCs.  
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Figure 19: LIVE/DEAD staining of hMSCs on microthreads 
Ki-67 staining of bundles showed that hMSCs are entering the cell cycle over 5 
days in culture on microthreads. Figure 20 shows Hoechst dye, Ki-67, and overlay 
images at 1, 3, and 5 days in culture. Few cells enter the cell cycle after 1 day, however 
by day 3 there is a statistical increase in the number of Ki-67+ hMSCs.  Staining is still 
present at day 5 however there is a statistically significant decrease in percentage of 
positive cells from day 3. Table 7 shows a summary of the percentage of Ki-67 
expression at each time point.  Data was taken from 10 randomly selected images of 4 
bundles stained in two separate experiments. An average of 69 cells was examined per 
image (~ 690 cells per time point).  
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Table 7: Percent of Ki-67 positive hMSCs on microthreads (Average + Stdev) 
Time Point % hMSCs in cell cycle 
1 Day 4.9 + 5.4 
3 Day 22.6 + 5.9* 
5 Day 6.8 + 5.7† 
(* indicates statistically significant differences between day 1  
and day 3 p<0.05, † indicates statistically significant difference  
between day 3 and day 5) 
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Figure 20: Ki-67 of hMSCs on microthreads 
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Our Hoechst dye counts indicated hMSCs seemed to be proliferating faster than 
commonly observed in culture. Therefore we coated chamber slides with a thin layer of 
fibrin to investigate its effect on proliferation rates. Drying fibrin gels in 8-well chamber 
slides resulted in adherence of a thin film of fibrin to the bottom of the wells. Trypan 
blue staining in Figure 21 shows the presence of this coating. The non trypan blue 
stained wells indicate the presence of crystals in the fibrin layer. After rinsing with 
10mM HEPES and sterilizing, the crystals were eliminated and a uniform coating of 
fibrin remained.  
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Figure 21: Trypan Blue staining of fibrin coatings 
Ki-67 staining of hMSCs seeded on standard 8-well chamber slides is shown in 
Figure 22 and fibrin coated 8-well chamber slides is shown in Figure 23.  The percentage 
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of cells in the cell cycle at each time point is shown in Table 8. Data is taken from 10 
randomly selected images of 4 wells of 2 chamber slides stained in two separate 
experiments. An average of 30 and 18 cells was examined per image for standard and 
fibrin coated slides respectively (~300 and ~180 cells per time point). 
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Figure 22: Ki-67 on non-coated chamber slides 
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Figure 23: Ki-67 on fibrin coated chamber slides 
 
 The percentage of Ki-67 positive hMSCs on standard, uncoated chamber slides 
showed a statistical increase after 1 day in culture. Between 3 days and 5 days in culture 
there was no statistically significant difference in the percentage of Ki-67 positive 
hMSCs. Data from fibrin coated chamber slides showed no statistical increases in 
percent expression over 5 days in culture.  
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Table 8: Percent of Ki-67 positive hMSCs on chamber slides (Average + Stdev) 
Time Point % hMSCs in cell cycle: uncoated % hMSCs in cell cycle: fibrin coated 
1 Day 10.3 + 10.4      20.1 + 19.0 
3 Day 26.2 + 12.7* 33.3 + 18.3 
5 Day 29.0 + 12.3* 20.8 + 8.1 
(* indicate statistically significant difference from 1 day for p<0.05) 
The graph in Figure 24 compares the percentage of Ki-67+ cells on microthreads, 
standard chamber slides, and fibrin coated chamber slides. Ki-67 expression by hMSCs at 5 days 
on microthreads was statistically lower than expression on uncoated or fibrin coated slides. All 
other combinations showed no statistical difference.  
 
(* indicates statistically significant difference between 5 day microthreads and uncoated, coated slides for p<0.05, there is no 
statistical difference between uncoated and coated slides) 
Figure 24: Comparison of Ki-67 expression on different substrates 
 
 
* 
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5.3 Differentiation 
 Functional differentiation assays proved that hMSCs retained their ability to 
differentiate into adipocytes and osteocytes after being cultured on microthread 
bundles for 5 days. Both experiments were repeated to n = 2 with treated control (n = 6), 
untreated control (n = 6), and hMSCs from threads (n = 4) for each experiment. After 3 
weeks in culture, treated hMSCs began to form lipid vacuoles as seen in Figure 25. Oil 
Red O staining after 5 weeks of culture confirmed the presence of lipid vacuoles as seen 
in Figure 26.  
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Figure 25: Adipogenic differentiation 
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Untreated hMSCs (non-thread) Treated hMSCs (non-thread) Treated hMSCs (from threads) 
   
Figure 26: Oil Red O staining of lipid vacuoles 
After 4 weeks in culture, Alizarin Red S staining of osteogenic cultures showed 
extensive calcium deposition by treated hMSCs, indicating their differentiation into 
osteocytes (Figure 27).  
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Figure 27: Osteogenic differentiation 
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Within the osteogenic cultures were small clusters of adipocytes, as seen in 
Figure 28. This only occurred in wells with hMSCs that had been trypsinized from 
threads, with less than 10 adipocytes present per well. All other treated controls 
contained no adipocytes. The red staining is Alizarin Red S for calcium deposition.  
  
Figure 28: Adipocytes present in osteogenic cultures 
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Chapter 6: Discussion 
This project has succeeded in quantifying the number of hMSCs attached to a 
bundle of four fibrin microthreads, confirmed they enter the cell cycle and remain 
viable, as well as verified their ability to maintain multipotency. This section discusses 
the significance of these results in terms of the goal of this project.  
6.1 Quantification of Cell Number: Hoechst dye 
Counts of Hoechst dye stained nuclei indicated that we can achieve an average 
density of 731 + 101 cells/mm2 of microthread. By extrapolating this data to calculate the 
total number of cells per microthread bundle, we find that it is theoretically possible to 
deliver approximately 10,000 cells with one 2 cm long bundle. This coincides well with 
our predicted hMSC attachment of 15,000 cells on a bundle of microthreads and falls 
within the range of 400 to 40,000 cells that must be delivered to the rat heart to see 
functional improvements (refer to Table 2 for data and references).  
While a single microthread bundle will deliver 10,000 cells, 4 bundles will deliver 
approximately 40,000 cells which is the upper end of the desired delivery range.  
Delivering 1 to 4 microthread bundles to the rat heart is feasible, as their diameter is 
only a fraction of the wall thickness of infarcted rat hearts (1.5 to 2mm) [81]. Delivering 
the entire 2 cm length of microthread in one pass may difficult. However with multiple 
passes, either in parallel or around the infarct zone, the necessary length of microthread 
bundle could be implanted. The length of microthread needed could also be shortened 
if the number of microthreads per bundle were increased, providing a larger 
circumferential surface area for cell attachment and growth.  
These calculations assume that the engraftment rate of hMSCs delivered by 
suturing the microthread bundle into the heart wall is 90 to 100%. However, this has not 
been evaluated as of yet. Since the hMSCs are cultured on the exterior of the 
microthread bundle, shear stress will be exerted on them during delivery. There is a 
distinct possibility that the shear stress these cells encounter while the microthread 
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bundle is being sutured into the myocardium could detrimentally impact cell viability 
and adhesion. While this work shows microthread bundles support hMSC attachment 
and growth, it is unknown how much shear stress hMSCs can handle before becoming 
unattached from the bundle. Should this be identified as a problem, there are at least 
two approaches that could be implemented to try and protect the hMSCs from shear 
stress.   
One is to utilize a sheath of silicone tubing or similar material to protect hMSCs 
during delivery. This protective sheath would then be removed once the microthread is 
implanted. The protective sheath could also serve as a bioreactor for culture of hMSCs 
on microthreads pre-implantation. However, this approach may limit the surgeon’s 
ability to freely suture the microthreads in curved or circular patterns based on the 
flexibility of the sheath. Also, it will still expose hMSCs to shear stress while the sheath 
is being removed. If the material used is rigid and there is enough clearance space 
between the inner wall and the microthread this may not pose a problem. However 
since fibrin microthreads have a tendency to adhere to anything in their proximity, it is 
inevitable that the hMSCs would still be experiencing enough shear stress to decrease 
engraftment rates.  
A second approach would be to develop an alternative method to bundling the 
fibrin microthreads to create a protective layer. If bundling were controlled so hMSCs 
were more concentrated in the grooves of the bundle rather than over the outer surface 
then they would be protected during implantation. Any shear stress experienced would 
be exerted on the outermost portions of the microthread bundle. This could also be 
achieved by coating the seeded microthread bundle in a fibrin gel to serve as a 
lubricant. Or alternatively, this could be achieved by co-extruding the hMSCs within 
the microthread bundles. While this could be a relatively simple solution, this presents 
issues with ensuring all cells remain viable and oxygen and nutrients are able to diffuse 
to the entrapped cells.  
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No matter the procedure for delivery, it is still vital to investigate how many cells 
are lost in the microthread implantation process and how this would affect the 
engraftment rate. We expect a much higher engraftment rate than systemic delivery 
because the cells are delivered locally and are attached to the microthread scaffold 
which should minimize, or even eliminate, the wash out phenomenon that has limited 
cell retention when direct intramyocardial injection is used as a delivery method.  
6.2 Quantification of Cell Number: CyQuant Assay 
We attempted to develop an automated, high throughput assay for cell 
quantification that would be more reproducible and time efficient than hand counting 
nuclei in images. While the Hoechst dye counting allows the researcher to analyze 
threads intact and provides more detailed analysis, it is time consuming and can be 
skewed by the different focal planes present when viewing with a standard upright 
microscope. Thus many nuclei are out of focus or not seen and as a result aren’t 
included in the quantification. The use of confocal microscopy is highly recommended 
for any further quantification with Hoechst dye staining. Confocal microscopy allows 
images to be taken in one plane at a time, thus eliminating out of focus objects and 
building a three dimensional image of the sample. Viewing the microthreads in this 
way would allow all the nuclei present on any plane to be counted and included in 
quantification. 
The CyQuant assay reported less than half of the total number of cells counted in 
the Hoechst dye analysis. A comparison between two standard curves (Figure 29) 
illustrates this loss of cells.  The standard curve labeled ‘plated’ was made by incubation 
of CyQuant dye on known numbers of hMSCs cultured in a standard tissue culture 
plate. The standard curve labeled ‘digestion/re-plate’ was made by taking known 
numbers hMSCs cultured in a standard tissue culture plate, and trypsinizing, 
centrifuging, re-plating, and then rinsing them before application of the CyQuant dye. 
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This is the same protocol that was used for quantification of hMSC attachment on 
microthreads. The discrepancy between the two slopes (31.0 as compared to 9.4) 
signifies that cells are being lost somewhere in the assay.   
 
Figure 29: CyQuant standard curve comparison 
One possible explanation is that the plate reader is not picking up the emitted 
fluorescence from all areas of the well. More often than not a significant number of re-
plated cells are very close to the edge of the tissue culture well. Depending on the plate 
reader capabilities, it may not be able to gather signal from this part of the well. While 
verification steps proved minimal cell losses in centrifuge supernatant and PBS rinses, 
the trypsinization process could be digesting cells along with the fibrin microthread. 
Thus these cells would be lost before the assay process even began. Finally, it is possible 
that cells could remain attached to the thread debris and are rinsed away during the re-
plating process. This was not investigated directly, however the amount of thread 
debris remaining after digestion would not easily lend itself to carrying half of the total 
number of cells present on the bundle.  
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Further refinement of the CyQuant assay is needed before we can be confident in 
its results. There are a variety of approaches that can be taken to attempt to narrow 
down the problem. First, to identify if the trypsinization process is killing the hMSCs, 
the cells can be subject to trypsinization, centrifuged, re-suspended and then counted 
via hemocytometer. Comparing this count to bundles of microthread digested and 
evaluated via the entire CyQuant assay procedure will illustrate whether or not 
trypsinization is the problem. For the seeding of the functional differentiation assays, 
we had to trypsinize the hMSCs from the microthreads and count them via 
hemocytometer in order to re-plate the cells at the appropriate concentration. This data 
provides a comparison technique for determining whether the discrepancy between the 
Hoechst dye results and the CyQuant results is due to the trypsinization process. 
Looking back at the cell counts shows there were a total of 37,440 cells digested from 36 
microthread bundles. Thus, there were only just over 1,000 cells present per 
microthread bundle. This indicates that the hemocytometer counts and the CyQuant 
assay are in agreement with each other and thus there is a pretty good chance 
trypsinization is affecting the measurement of cell number.  This verification process 
should be repeated to confirm these results.  
Second, further verification should be performed by Hoechst dye staining the re-
plated supernatant and PBS from rinsing.   This will identify the presence of any cells 
still attached to the thread debris. This should be done by re-suspending these solutions 
in Hoechst dye, then centrifuging again and re-suspending in PBS to rinse the excess 
Hoechst dye. This is necessary because the thread debris will not adhere to the tissue 
culture plate when re-plated. Finally, if no previous verification reveals significant cell 
loss then this may indicate that reading of the emitted fluorescence by the plate reader 
is a problem. An alternative form of the CyQuant assay involves a freeze-thaw cycle to 
lyse cells and release the DNA into solution. This may alleviate problems due to cell 
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distribution within the well because it would allow the DNA to be in a homogenous 
solution when analyzed by the plate reader. 
6.3 Cell Proliferation 
Ki-67 staining of hMSCs cultured on microthread bundles illustrated that the 
increase in cell number over time is due to proliferation. It was necessary to confirm this 
because each sample in this experiment was taken individually. There was no carryover 
of samples from one time point to the next therefore it could be argued that any changes 
in cell number may be due to variation between samples. Since Ki-67 staining revealed 
that hMSCs are proliferating on microthreads, we know this increase is not sample 
variation but growth of hMSCs on the surface over time.  
Typical doubling time for low passage (P2-10) hMSCs in culture is 5 to 7 days 
[78]. Looking at the data from Hoechst dye counts before analysis, hMSCs appear to be 
proliferating much faster, increasing 7-fold over 5 days. In order to determine if this 
increase is due to the substrate the hMSCs are being cultured on we compared 
proliferation rates on microthread bundles to that of standard chamber slides and fibrin 
coated chamber slides. The only significant difference in this comparison was the 
decrease in expression rate at 5 days on microthread bundles. Instructions from Lonza, 
the hMSC supplier, cite that hMSCs seeded at a concentration of 5,000 - 6,000 cells/cm2 
should reach confluence in 6 to 7 days. Quantification results show that hMSCs are 
initially seeded on microthreads at a concentration of 9,300 + 2,100 cells/cm2. Thus, we 
presume this decrease in Ki-67 expression may be due to the hMSCs beginning to reach 
confluence on the microthread bundle, thus their proliferation rates would be 
decreasing.  
While this data suggests that hMSC proliferation on microthread bundles is no 
different from hMSC proliferation on a standard or fibrin coated culture surface, there 
are some limitations with this experiment. Both fibrin coated and uncoated chamber 
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slides were seeded at the same density, however there are statistically fewer cells 
present in the images counted for the fibrin coated chamber slides (18 + 8 cells/image for 
fibrin coated compared to 30 + 17 cells/image for uncoated). It is unknown why so few 
cells appear on the fibrin coated surface. Also, the initial purpose of this experiment was 
solely to demonstrate the presence of proliferation markers to support the claim that 
increases in cell number over time were due to cell growth. In order to make thorough 
comparisons of Ki-67 expression between chamber slides and microthreads, the 
chamber slides would have been seeded at a comparable density to what is observed on 
microthread bundles. Cells on chamber slides were seeded at what is equivalent to 28 
cells/mm2 while after 5 hours on microthreads the average cell density is just over 90 
cells/mm2. This renders comparison between the two in their current state somewhat 
futile because cells seeded at different densities will proliferate at different rates.  
6.4 Differentiation 
 Functional differentiation assays demonstrated that hMSCs retain their ability to 
differentiate down adipogenic and osteogenic lineages after 5 days of culture on fibrin 
microthreads. This was expected as previous research has shown hMSCs can 
differentiate down both lineages when cultured in a fibrin gel [82, 83]. Catelas et al. 
investigated hMSC morphology, proliferation and osteogenesis in different 
formulations of fibrin gels. Cells entered into the early stages of osteogenic 
differentiation as measured by alkaline phosphatase assay, von Kossa staining, and 
real-time reverse transcriptase-polymerase chain reaction [82]. Additionally, Gerard et 
al. demonstrated adipogenic differentiation of hMSCs cultured in a fibrin gel as 
documented by Oil Red staining [83]. 
While our work shows that hMSCs retain their multipotency in terms of 
adipogenic and osteogenic lineages, we believe there is reason for further investigation.  
After 4 weeks of culture there were small pockets of adipocytes present in the Alizarin 
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Red S stained osteogenic wells of hMSCs that had been cultured on threads. This could 
indicate that hMSCs are predisposed to adipogenesis after culture on microthreads 
since adipocytes were not present in any other group. However, presence of adipocytes 
in these cultures was deduced solely by phenotype and was not confirmed by Oil Red 
staining. Also, this experiment did not include staining of non-induced hMSCs grown 
on fibrin microthreads. This important control would shed light on whether adipocytes 
spontaneously form in hMSC cultures from microthreads. Research in adipose tissue 
engineering cites the use of fibrin gels for supporting the growth of pre-adipocytes [84-
86]. However, while Matrigel alone has been shown to produce spontaneous 
adipogenesis in murine models, research with fibrin gels to date shows no induction of 
adipogenesis [86, 87].  
In order to do these experiments, the microthreads were removed from culture 
and digested in the same manner as the CyQuant assay. If the trypsinization process is 
killing some of the cells while it digests the microthread bundle as suspected, then we 
are potentially selecting for hMSCs that survive this process. If it is, then the digestion 
procedure will need to be eliminated in order to test the multipotency of all cells 
present. The microthread bundles could be cut from the washers, placed in the bottom 
of 12-well tissue culture plates and fed with the appropriate medium. In this way, no 
hMSCs are specifically selected for through any sort of digestion process and they are 
allowed to continue growing on the microthread during the feeding cycle. It is assumed 
that the cells would eventually break down the microthread and spread out to cover the 
bottom of the well during this cycle.  
Adipogenesis and osteogenesis are only two of the many lineages hMSCs have 
been shown to differentiate into. Research suggests hMSCs are also capable of 
chondrogenic, myogenic, neurogenic and endothelial differentiation thus complete 
characterization of their multipotency would include these assays [37]. Barry et al. 
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demonstrated chondrogenic differentiation of MSCs when grown in a three 
dimensional culture format in a serum free medium with the presence of a member of 
the TGF-β family [88]. Endothelial differentiation was shown by Davani et al. after 
intramuscular injection of MSCs into a rat infarct model [89]. The MSCs differentiated 
into an endothelial phenotype and improved vascularization of the area. Deng et al. 
illustrated the neurogenic potential of MSCs when treated with isobutylmethlyxanthine 
and dibutyryl cyclic AMP after 6 days in culture. Finally, hMSCs injected into the 
myocardial wall of mice showed expression of desmin, β-myosin heavy chain, α-
actinin, cardiac troponin T, and phospholamban at levels comparable to those of the 
host cardiomyocytes, indicating myogenic differentiation [8].  
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Chapter 7: Future Work and Implications 
The use of fibrin microthreads as a biological scaffold for stem cell delivery to 
infarcted myocardium is a novel approach. This section describes some of the 
implications of these results and their significance for future investigations. 
These fibrin microthreads are meant to be delivered to the heart in the same 
manner as a suture. This is highly advantageous because surgeons use suture as part of 
their daily routine, thus it would not require any special instructions or training for use. 
When used as a suture, the cell-seeded microthreads have the ability to be implanted to 
a precise location within the heart wall, thus localizing the therapeutic treatment where 
it is most needed. Some caution must be exercised with their use however, because the 
microthreads still need ready access to blood flow for the cells they are carrying to 
remain viable. The bundles could be sutured around the infarct at the border zone or 
within healthy myocardium and be in the presence of perfused tissue. If they are 
sutured directly through the center of the infarct zone it is likely that many of the cells 
with have difficulty surviving due to the diminished availability of nutrients within the 
harsh environment.  
It is important to note that the mechanism by which the delivery of hMSCs aid in 
functional cardiac improvements is highly controversial. Several different mechanisms 
have been proposed, including passive presence of additional cells or materials within 
the myocardial wall, differentiation of transplanted cells, and paracrine signaling [35, 
44]. Cell-seeded fibrin microthreads have the potential to function by all of these three 
mechanisms. Studies have shown that the delivery of passive material alone to the 
myocardium results in improved mechanical function [90] thus the presence of the 
fibrin microthread alone may help improve heart function. Other research, including 
Kajstura et al. and Toma et al., has demonstrated transdifferentiation of hMSCs upon 
implantation in murine myocardium [8, 91]. The latter study demonstrated that these 
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cells expressed levels of desmin, β-myosin heavy chain, α-actinin, cardiac troponin T, 
and phospholamban comparable to host cardiac myocytes with sarcomeric organization 
of contractile proteins [8]. Since fibrin microthreads are able to support the growth of 
undifferentiated hMSCs, these cells have the potential to differentiate in a similar 
manner once implanted into the myocardium. And finally, other groups have 
demonstrated improvements in cardiac mechanics attributed to paracrine effects 
initiated by introduction of MSCs [44, 91-93].    MSCs are known to secrete growth 
factors and cytokines such as vascular endothelial growth factor (VEGF), basic 
fibroblast growth factor (bFGF), insulin-like growth factor (IGF), and stromal cell 
derived factor (SDF) which may prevent apoptosis of cardiomyocytes, induce 
adipogenesis, and activate resident progenitor cells [91-93]. Thus delivery of hMSC-
seeded microthreads to the infarct border zone would allow hMSCs to interact with the 
native myocytes in this way as well.  
Another attractive feature of using fibrin microthreads is inherent in their 
combination of cell signaling and structural properties. Specifically, their cylindrical 
structure and small diameter facilitate orientation of cells based on the organization of 
the cell’s actin microfilament bundles [94]. The structure of the heart consists of highly 
oriented muscle fibers strongly correlated to heart function. By guiding alignment of 
hMSCs on the fibrin microthreads, we may provide an aligned environment for 
regeneration. Our results hinted that hMSCs appear to align with the long axis of the 
fibrin microthread bundle. While this was not quantified, it may be an area for future 
development to characterize fibrin microthreads as a matrix for cell alignment as well.  
An important consideration for any biomaterial delivery scaffold is persistence 
within the tissue. The fibrin microthreads should persist long enough to guide the 
integration of cells, but not so long as to interfere with cell coupling essential to 
myocardial function [54]. Fibrin is known for its rapid clearance upon implantation by 
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cellular mechanisms [48] thus it will be necessary to investigate their persistence in-
vivo. Should the fibrin microthreads degrade too rapidly in their natural state, they can 
be crosslinked. However cross-linking of microthreads by ultraviolet light has shown a 
negative impact on cell proliferation when examined with fibroblasts [23]. Therefore an 
alternative form of cross-linking may need to be explored, such as those suggested by 
Cornwell et al. including cross-linking by aldehydes or use of enzymes from the 
transglutaminase family [23].  
In summary, this study has begun to validate the use of fibrin microthreads as a 
platform technology for delivery of hMSCs to myocardial infarcts. While our work was 
done with a bundle of 4 fibrin microthreads, this technology has the capability for scale-
up to accommodate increased number of cells to be applicable for the human heart. 
Either by increasing the number of threads per microthread bundle or by increasing the 
length of the bundles, the surface area for cell seeding and attachment can be increased. 
Fibrin microthreads can also be utilized as a platform for growth factor delivery. 
Previous studies have identified the growth factors that are up-regulated by hMSCs 
when transplanted into a myocardial infarct. By incorporation of these growth factors 
(such as VEGF, bFGF, IGF, SDF, or hepatocyte growth factor (HGF)) the microthreads 
can assist the hMSCs in controlling the microenvironment of the resident cardiac 
myocytes. Additionally, by combining the incorporation of growth factors with 
compounds such as 5-azacytdine or transcription factor Pax3, hMSCs grown on 
microthreads could be encouraged down a myogenic pathway [95]. This would control 
the fate of implanted hMSCs and potentially accelerate myocardial regeneration. 
Ultimately, this technology could further revolutionize surgical therapy for myocardial 
infarcts if it were adapted to be a semi or minimally invasive procedure. This would 
eliminate the need for open heart surgery, making this technology available to patients 
deemed too high risk for such invasive procedures.   
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Conclusions 
The goal of this project was to explore several fundamental questions regarding 
the feasibility of culturing human mesenchymal stem cells on a fibrin microthread 
scaffold as a first step toward developing a microthread-mediated cell delivery system. 
Our results demonstrate that microthread bundles have the potential to deliver a 
physiologically relevant number of cells to the heart and that these hMSCs are viable, 
can proliferate on the microthread bundle, and retain their stemness after 5 days of 
culture. This study validates the feasibility of using cell-seeded microthreads as a 
platform technology to improve localized delivery of viable cells to infarcted 
myocardium for promotion of functional tissue regeneration. 
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Appendix A: Measurement of Cell Area 
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Appendix B: Cell Attachment Counts 
Summary of counts: average and standard error of mean 
Bundle of 4 EXP1 
  
Bundles of 4 EXP2 
 5h Cells/mm Cells/mm2 5h Cells/mm Cells/mm2 
slide 1 38.47518 101.6026 
 
slide 1 16.89665 54.07025 
slide 2 30.56596 65.79344 
 
slide 2 17.30985 40.40646 
slide 3 48.18168 176.1056 
 
slide 3 73.14241 118.6572 
SEM 5.094034 32.49083 
 
SEM 18.6801 24.13084 
Avg 39.07427 114.5005 
 
Avg 35.78297 71.04464 
1 day Cells/mm Cells/mm2 1 day Cells/mm Cells/mm2 
slide 1 57.57516 236.3595 
 
slide 1 86.53155 217.9929 
slide 2 127.1818 375.2458 
 
slide 2 272.8309 455.0261 
slide 3 54.73251 163.7388 
 
slide 3 32.41627 71.52234 
SEM 23.6902 62.04765 
 
SEM 72.8145 111.7322 
Avg 79.82982 258.4481 
 
Avg 130.5929 248.1805 
2 day Cells/mm Cells/mm2 
 
2 day Cells/mm Cells/mm2 
slide 1 88.85961 227.2843 
 
slide 1 242.0238 569.2331 
slide 2 56.56934 176.0828 
 
slide 2 32.96182 85.92396 
slide 3 86.52021 265.8301 
 
slide 3 207.1453 570.776 
SEM 10.39548 25.99353 
 
SEM 64.66293 161.3608 
Avg 72.71448 201.6835 
 
Avg 137.4928 327.5785 
3 day Cells/mm Cells/mm2 
 
3 day Cells/mm Cells/mm2 
slide 1 227.8468 658.5979 
 
slide 1 197.5338 622.6984 
slide 2 186.7754 700.3155 
 
slide 2 147.5344 447.4031 
slide 3 200.7821 486.0349 
 
slide 3 196.5623 412.3011 
SEM 12.05439 65.589 
 
SEM 16.50695 65.07583 
Avg 207.3111 679.4567 
 
Avg 172.5341 535.0508 
4 day  Cells/mm Cells/mm2 
 
4 day  Cells/mm Cells/mm2 
slide 1 369.1283 832.6093 
 
slide 1 350.1025 752.9059 
slide 2 144.1597 413.1605 
 
slide 2 287.8568 657.5484 
slide 3 254.6065 717.9605 
 
slide 3 140.6223 319.0781 
SEM 64.94638 125.1632 
 
SEM 62.10857 131.627 
Avg 256.644 622.8849 
 
Avg 318.9797 705.2271 
5 day  Cells/mm Cells/mm2 
 
5 day  Cells/mm Cells/mm2 
slide 1 262.5418 837.8298 
 
slide 1 454.2129 783.4643 
slide 2 110.8269 297.8002 
 
slide 2 283.5794 602.7357 
slide 3 300.6728 1002.742 
 
slide 3 476.5664 858.9071 
SEM 57.98127 212.8864 
 
SEM 60.94598 76.00374 
Avg 186.6843 567.815 
 
Avg 368.8961 693.1 
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Bundle of 4 EXP1: P6 and 7 hMSCs 
   
Total 
  5h Picture # Mag Area (um2) Length (um) # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 20x 294251.217 679 6 8.8 20.3907398 217 5640 38.47518 
 
2 20x 291347.541 679 19 28.0 65.214211 
   
 
3 20x 311425.56 722 29 40.2 93.1201665 
  
Cells/mm2 
 
4 20x 294709.286 714 55 77.0 186.624591 
  
101.6026 
 
5 20x 258259.393 723 66 91.3 255.557017 
   
 
6 20x 215465.85 748 13 17.4 60.3343871 
   
 
7 20x 219882.017 695 27 38.8 122.793125 
   
 
8 20x 227629.866 680 2 2.9 8.78619328 
   
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 20x 153745.19 514 1 1.9 6.50426852 155 5071 30.56596 
 
2 20x 199416.096 507 12 23.7 60.1756841 
  
Cells/mm2 
 
3 20x 226963.841 509 5 9.8 22.0299409 
  
65.79344 
 
4 20x 230863.937 508 15 29.5 64.9733354 
   
 
5 20x 248514.175 511 25 48.9 100.597883 
   
 
6 20x 243401.921 504 23 45.6 94.4939132 
   
 
7 20x 246942.763 500 24 48.0 97.1885133 
   
 
8 20x 246942.763 506 20 39.5 80.9904277 
   
 
9 20x 222976.248 508 10 19.7 44.8478261 
   
 
10 20x 232200.232 504 20 39.7 86.1325582 
   
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 20x 203367.05 644 32 49.7 157.350957 314 6517 48.18168 
 
2 20x 166392.669 678 35 51.6 210.345806 
  
cells/mm2 
 
3 20x 189412.842 732 44 60.1 232.296815 
  
176.1056 
 
4 20x 192417.171 730 54 74.0 280.640235 
   
 
5 20x 170727.988 755 21 27.8 123.00268 
   
 
6 20x 160431.474 760 29 38.2 180.762535 
   
 
7 20x 213879.584 715 31 43.4 144.94137 
   
 
8 20x 264218.043 750 38 50.7 143.82061 
   
 
9 20x 268361.603 753 30 39.8 111.789465 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 10x 254265.811 1455 45 30.9 176.980145 586 10178 57.57516 
 
2 10x 311823.91 1435 64 44.6 205.244043 
   
 
3 10x 362271.361 1439 133 92.4 367.12811 
  
cells/mm2 
 
4 10x 403143.427 1481 164 110.7 406.80311 
  
236.3595 
 
5 10x 346049.832 1495 101 67.6 291.865479 
   
 
6 10x 390712.221 1456 59 40.5 151.006282 
   
 
7 10x 360428.084 1417 20 14.1 55.4895717 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 284804.891 1394 92 66.0 323.02816 1246 9797 127.1818 
 
2 10x 406217.482 1374 274 199.4 674.51553 
  
cells/mm2 
 
3 10x 493783.674 1415 347 245.2 702.736883 
  
375.2458 
 
4 10x 550053.763 1429 307 214.8 558.127261 
   
 
5 10x 614580.587 1412 197 139.5 320.543805 
   
 
6 10x 607085.79 1391 25 18.0 41.1803412 
   
 
7 10x 607085.79 1382 4 2.9 6.5888546 
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Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 572062.088 1424 51 35.8 89.1511622 532 9720 54.73251 
 
2 10x 488479.593 1386 73 52.7 149.443295 
  
cells/mm2 
 
3 10x 507182.622 1369 126 92.0 248.431225 
  
163.7 
 
4 10x 460011.851 1412 96 68.0 208.690276 
   
 
5 10x 422499.133 1378 60 43.5 142.012126 
   
 
6 10x 398442.016 1379 83 60.2 208.311364 
   
 
7 10x 429432.304 1372 43 31.3 100.132197 
   
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 20x 280198.549 682 39 57.2 139.187016 607 6831 88.85961 
 
2 20x 339067.381 679 43 63.3 126.818451 
  
cells/mm2 
 
3 20x 339067.381 679 72 106.0 212.347174 
  
227.2843 
 
4 20x 339067.381 679 64 94.3 188.753043 
   
 
5 20x 339067.381 679 64 94.3 188.753043 
   
 
6 20x 270391.58 672 64 95.2 236.693761 
   
 
7 20x 215265.533 682 78 114.4 362.34319 
   
 
8 20x 204517.811 687 73 106.3 356.937128 
   
 
9 20x 232964.152 698 68 97.4 291.890402 
   
 
10 20x 248344.981 694 42 60.5 169.119585 
   
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 20x 285193.031 690 30 43.5 105.191911 310 5480 56.56934 
 
2 20x 208625.792 694 30 43.2 143.798136 
  
cells/mm2 
 
3 20x 229319.899 697 38 54.5 165.707382 
  
176.0828 
 
5 20x 293787.489 683 46 67.3 156.575762 
   
 
6 20x 144148.724 686 35 51.0 242.804785 
   
 
7 20x 208720.999 680 41 60.3 196.434476 
   
 
8 20x 211169.718 680 46 67.6 217.834264 
   
 
9 20x 244016.382 670 44 65.7 180.315763 
   
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 455877.847 1399 78 55.8 171.098465 957 11061 86.52021 
 
2 10x 463226.385 1406 192 136.6 414.484162 
  
cells/mm2 
 
3 10x 454440.398 1376 170 123.5 374.086461 
  
265.8301 
 
4 10x 415705.862 1376 161 117.0 387.293071 
   
 
5 10x 473802.752 1376 144 104.7 303.923942 
   
 
6 10x 457658.111 1376 119 86.5 260.019427 
   
 
7 10x 435424.327 1376 67 48.7 153.872891 
   
 
8 10x 420287.316 1376 26 18.9 61.8624427 
   
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 0 10x 453695.225 1380 118 85.5 260.086493 2201 9660 227.8468 
 
1 10x 463917.216 1380 304 220.3 655.289326 
  
cells/mm2 
 
2 10x 509948.549 1380 449 325.4 880.480984 
  
658.5979 
 
3 10x 489614.695 1380 467 338.4 953.811241 
   
 
4 10x 464253.671 1380 446 323.2 960.681687 
   
 
5 10x 490734.189 1380 296 214.5 603.177864 
   
 
6 10x 407877.789 1380 121 87.7 296.657487 
   
           
           
           
        
Total 
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3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 0 10x 443907.966 1380 79 57.2 177.964817 2062 11040 186.7754 
 
1 10x 444348.769 1380 263 190.6 591.877413 
  
Cells/mm2 
 
2 10x 338906.232 1380 335 242.8 988.474004 
  
700.3155 
 
3 10x 390678.113 1380 405 293.5 1036.65905 
   
 
4 10x 358381.894 1380 337 244.2 940.337683 
   
 
5 10x 326791.537 1380 325 235.5 994.517799 
   
 
6 10x 366435.426 1380 250 181.2 682.248446 
   
 
7 10x 357059.198 1380 68 49.3 190.444611 
   
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 440459.591 1386 50 36.1 113.517791 3132 15599 200.7821 
 
2 10x 525012.14 1393 111 79.7 211.423683 
  
Cells/mm2 
 
3 10x 432110.649 1386 78 56.3 180.509321 
  
486.0349 
 
4 10x 508060.758 1455 93 63.9 183.048973 
   
 
5 10x 508894.67 1386 298 215.0 585.582867 
   
 
6 10x 522932.131 1404 409 291.3 782.128264 
   
 
7 10x 615468.84 1450 494 340.7 802.640147 
   
 
8 10x 609031.102 1398 510 364.8 837.395657 
   
 
9 10x 650136.432 1450 503 346.9 773.683761 
   
 
10 10x 676063.707 1450 483 333.1 714.429713 
   
 
11 10x 635709.331 1441 103 71.5 162.023735 
   
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 0 10x 520041.045 1380 101 73.2 194.215439 6648 18010 369.1283 
old 1 10x 572961.614 1380 287 208.0 500.906157 
  
Cells/mm2 
 
2 10x 586835.472 1380 502 363.8 855.435678 
  
832.6093 
 
3 10x 578995.26 1380 647 468.8 1117.45302 
   
 
4 10x 605117.355 1380 759 550.0 1254.30215 
   
 
5 10x 648948.433 1380 872 631.9 1343.71231 
   
 
6 10x 677565.036 1380 855 619.6 1261.87149 
   
 
7 10x 646244.653 1380 800 579.7 1237.92127 
   
 
8 10x 577288.704 1380 633 458.7 1096.50509 
   
 
9 10x 606079.894 1410 456 323.4 752.376056 
   
 
10 10x 668796.971 1420 398 280.3 595.098389 
   
 
11 10x 582931.553 1380 255 184.8 437.444154 
   
 
12 10x 469778.009 1380 83 60.1 176.679194 
   
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 0 10x 403379.581 1380 45 32.6 111.557456 2419 16780 144.1597 
old 1 10x 425882.761 1380 140 101.4 328.728967 
  
Cells/mm2 
 
2 10x 398288.82 1380 138 100.0 346.482234 
  
413.1605 
 
3 10x 399096.427 1380 205 148.6 513.660324 
   
 
4 10x 415787.374 1380 282 204.3 678.231273 
   
 
5 10x 489953.752 1390 292 210.1 595.974618 
   
 
6 10x 513879.061 1430 280 195.8 544.875285 
   
 
7 10x 551923.922 1420 360 253.5 652.26381 
   
 
8 10x 583819.517 1410 316 224.1 541.263166 
   
 
9 10x 560582.437 1420 230 162.0 410.28756 
   
 
10 10x 551621.286 1410 96 68.1 174.032443 
   
 
11 10x 577857.556 1400 35 25.0 60.5685599 
   
           
           
        
Total 
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4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 600474.043 1397 107 76.6 178.192548 3565 14002 254.6065 
18-Jan 2 10x 470249.451 1376 227 165.0 482.72252 
  
Cells/mm2 
 
3 10x 446011.678 1376 356 258.7 798.185378 
  
717.9605 
 
4 10x 463998.728 1421 442 311.0 952.588818 
   
 
5 10x 554956.064 1376 725 526.9 1306.40973 
   
 
6 10x 550772.344 1406 716 509.2 1299.99265 
   
 
7 10x 481793.56 1488 524 352.2 1087.60275 
   
 
8 10x 456053.301 1410 284 201.4 622.734227 
   
 
9 10x 409962.423 1376 128 93.0 312.223738 
   
 
10 10x 403014.799 1376 56 40.7 138.952714 
   
           
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 10x 398038.791 1557 71 45.6 178.374575 3454 13156 262.5418 
 
2 10x 406542.953 1427 222 155.6 546.067761 
  
Cells/mm2 
 
3 10x 425436.467 1444 390 270.1 916.705619 
  
837.8298 
 
4 10x 509410.915 1503 596 396.5 1169.97886 
   
 
5 10x 526288.299 1514 875 577.9 1662.58684 
   
 
6 10x 430751.243 1389 630 453.6 1462.56107 
   
 
7 10x 410313.331 1417 392 276.6 955.367448 
   
 
8 10x 422855.243 1416 220 155.4 520.272608 
   
 
9 10x 451174.124 1489 58 39.0 128.553472 
   
           
           
           
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 604019.251 1376 117 85.0 193.702435 1083 9772 110.8269 
 
2 10x 444570.471 1424 200 140.4 449.872434 
  
Cells/mm2 
 
3 10x 476818.707 1376 222 161.3 465.58576 
  
297.8002 
 
4 10x 543339.114 1431 181 126.5 333.12529 
   
 
5 10x 591805.411 1533 178 116.1 300.77454 
   
 
6 10x 544376.228 1256 115 91.6 211.250959 
   
 
7 10x 537264.424 1376 70 50.9 130.289662 
   
           
           
           
           
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 397146.491 1413 141 99.8 355.032723 4290 14268 300.6728 
 
2 10x 407218.754 1443 300 207.9 736.704774 
  
Cells/mm2 
 
3 10x 374234.015 1376 404 293.6 1079.53843 
  
1002.742 
 
4 10x 370927.275 1385 488 352.3 1315.62178 
   
 
5 10x 376344.953 1528 674 441.1 1790.91016 
   
 
6 10x 471829.691 1376 774 562.5 1640.42241 
   
 
7 10x 520557.001 1539 673 437.3 1292.84593 
   
 
8 10x 441580.24 1439 421 292.6 953.39411 
   
 
9 10x 482880.102 1393 303 217.5 627.484957 
   
 
10 10x 475656.145 1376 112 81.4 235.464213 
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Bundle of 4 EXP2: P7 hMSCs 
        
Total 
  5h Picture # Mag Area (um2) Length (um) # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 459756.041 1433 45 31.4 97.87799613 120 7102 16.89665 
 
2 10x 413210.776 1378 23 16.7 55.66166551 
  
Cells/mm2 
 
3 10x 448468.32 1394 42 30.1 93.65210011 
  
54.07025 
 
4 10x 431788.068 1445 5 3.5 11.57975491 
   
 
5 10x 431788.068 1452 5 3.4 11.57975491 
   
           
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 431788.068 1374 1 0.7 2.315950982 170 9821 17.30985 
 
2 10x 595152.041 1375 9 6.5 15.12218623 
  
Cells/mm2 
 
3 10x 498598.393 1376 42 30.5 84.2361319 
  
40.40646 
 
4 10x 638338.536 1382 38 27.5 59.52954092 
   
 
5 10x 661510.579 1405 34 24.2 51.39751514 
   
 
6 10x 660638.802 1437 44 30.6 66.6022036 
   
 
7 10x 549191.236 1472 2 1.4 3.641718711 
   
           
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 594979.766 1493 21 14.1 35.29531793 756 10336 73.14241 
 
2 10x 841905.134 1454 104 71.5 123.5293572 
  
Cells/mm2 
 
3 10x 986395.248 1430 242 169.2 245.3377594 
  
118.6572 
 
4 10x 947011.215 1449 203 140.1 214.3586019 
   
 
5 10x 889429.125 1462 130 88.9 146.1611683 
   
 
6 10x 849019.829 1524 54 35.4 63.6027548 
   
 
7 10x 863730.778 1524 2 1.3 2.315536335 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 695109.839 1415 106 74.9 152.4938852 602 6957 86.53155 
 
2 10x 647520.523 1400 157 112.1 242.4633574 
  
Cells/mm2 
 
3 10x 528463.984 1383 161 116.4 304.6565232 
  
217.9929 
 
4 10x 416056.191 1381 111 80.4 266.7908864 
   
 
5 10x 542246.792 1378 67 48.6 123.5599749 
   
           
           
           
           
           
           
        
Total 
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1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 734105.966 1379 134 97.2 182.5349557 2632 9647 272.8309 
 
2 10x 803124.061 1377 475 345.0 591.4403802 
  
Cells/mm2 
 
3 10x 843084.75 1374 427 310.8 506.4734002 
  
455.0261 
 
4 10x 816049.832 1374 463 337.0 567.3673124 
   
 
5 10x 800555.556 1372 597 435.1 745.7321301 
   
 
6 10x 871938.952 1382 426 308.2 488.5663142 
   
 
7 10x 1067251.127 1389 110 79.2 103.0685255 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 478798.705 1404 32 22.8 66.83393181 271 8360 32.41627 
 
2 10x 588892.936 1394 30 21.5 50.94304612 
  
Cells/mm2 
 
3 10x 642848.306 1395 31 22.2 48.2228851 
  
71.52234 
 
4 10x 680076.888 1389 43 31.0 63.22814487 
   
 
5 10x 680076.888 1390 114 82.0 167.628105 
   
 
6 10x 650599.491 1388 21 15.1 32.27792258 
   
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 548981.385 1441 109 75.6 198.5495373 3095 12788 242.0238 
 
2 10x 620574.055 1447 350 241.9 563.9939298 
  
Cells/mm2 
 
3 10x 594954.33 1443 620 429.7 1042.096794 
  
569.2331 
 
4 10x 708530.466 1420 421 296.5 594.1875758 
   
 
5 10x 592675.165 1395 405 290.3 683.3422824 
   
 
6 10x 594150.191 1436 522 363.5 878.5657363 
   
 
7 10x 610188.461 1421 426 299.8 698.1449621 
   
 
8 10x 529928.894 1409 204 144.8 384.9573071 
   
 
9 10x 479433.75 1376 38 27.6 79.2601689 
   
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 666699.04 1540 56 36.4 83.99592116 278 8434 32.96182 
 
2 10x 495053.763 1372 136 99.1 274.7176371 
  
Cells/mm2 
 
3 10x 411688.635 1380 24 17.4 58.29648419 
  
85.92396 
 
4 10x 577970.286 1391 15 10.8 25.95289129 
   
 
5 10x 680311.019 1377 15 10.9 22.04873886 
   
 
6 10x 633261.36 1374 32 23.3 50.53205836 
   
           
           
           
           
           
        
Total 
  
86 
 
2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 621383.397 1424 32 22.5 51.49799649 2383 11504 207.1453 
 
2 10x 620325.471 1402 84 59.9 135.4127856 
  
Cells/mm2 
 
3 10x 520879.003 1413 238 168.4 456.9199346 
  
570.776 
 
4 10x 531843.566 1466 1145 781.0 2152.888694 
   
 
5 10x 535886.808 1545 443 286.7 826.6671121 
   
 
6 10x 436822.754 1504 317 210.8 725.6947975 
   
 
7 10x 546841.253 1374 104 75.7 190.1831645 
   
 
8 10x 742286.681 1376 20 14.5 26.94376784 
   
           
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 518822.407 1441 178 123.5 343.0846424 3235 13526 239.169 
 
2 10x 579489.536 1421 494 347.6 852.4744095 
  
Cells/mm2 
 
3 10x 580459.013 1376 651 473.1 1121.526215 
  
622.6984 
 
4 10x 592623.425 1547 683 441.5 1152.502536 
   
 
5 10x 570864.84 1630 542 332.5 949.4366477 
   
 
6 10x 579527.402 1528 379 248.0 653.9811555 
   
 
7 10x 574634.64 1437 126 87.7 219.2697607 
   
 
8 10x 558491.733 1456 123 84.5 220.2360263 Total 
  
 
9 10x 642884.148 1690 59 34.9 91.77392254 
   
           3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 548284.195 1397 86 61.6 156.852962 1834 12431 147.5344 
 
2 10x 440929.009 1375 177 128.7 401.4251646 
  
Cells/mm2 
 
3 10x 430457.856 1376 393 285.6 912.9813628 
  
447.4031 
 
4 10x 508272.633 1376 498 361.9 979.7891282 
   
 
5 10x 475250.896 1375 369 268.4 776.4319923 
   
 
6 10x 382837.322 1378 192 139.3 501.5185014 
   
 
7 10x 401199.561 1379 65 47.1 162.0141354 
   
 
8 10x 384120.997 1389 36 25.9 93.72046902 
   
 
9 10x 429650.249 1386 18 13.0 41.89454106 
   
           3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 734089.49 1406 57 40.5 77.64720893 2493 12683 196.5623 
 
2 10x 750198.578 1412 203 143.8 270.595021 
  
Cells/mm2 
 
3 10x 719980.923 1408 324 230.1 450.0119234 
  
412.3011 
 
4 10x 668119.147 1401 445 317.6 666.0488657 
   
 
5 10x 664143.254 1397 473 338.6 712.1957456 
   
 
6 10x 681953.983 1405 292 207.8 428.1813836 
   
 
7 10x 675551.509 1412 216 153.0 319.7387573 
   
 
8 10x 647053.417 1436 318 221.4 491.4586519 
   
 
9 10x 559639.265 1406 165 117.4 294.8327795 
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4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 666582.264 1376 55 40.0 82.51044615 5804 16578 350.1025 
 
2 10x 635588.507 1378 208 150.9 327.2557601 
  
Cells/mm2 
 
3 10x 662530.061 1385 344 248.4 519.2217233 
  
752.9059 
 
4 10x 650895.479 1381 482 349.0 740.5182791 
   
 
5 10x 559564.69 1382 562 406.7 1004.352151 
   
 
6 10x 581632.559 1385 667 481.6 1146.772115 
   
 
7 10x 611911.204 1385 667 481.6 1090.027435 
   
 
8 10x 641527.055 1378 759 550.8 1183.114561 
   
 
9 10x 702819.401 1383 826 597.3 1175.266361 
   
 
10 10x 707514.163 1379 787 570.7 1112.345224 
   
 
11 10x 681942.999 1384 355 256.5 520.5713682 
   
 
12 10x 692171.349 1382 92 66.6 132.9150652 
   
           
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 573624.118 1408 143 101.6 249.292168 4165 14469 287.8568 
 
2 10x 588637.415 1615 94 58.2 159.6908345 
  
Cells/mm2 
 
3 10x 629584.923 1379 386 279.9 613.1023566 
  
657.5484 
 
4 10x 629450.804 1377 469 340.6 745.0939724 
   
 
5 10x 599387.79 1376 630 457.8 1051.072462 
   
 
6 10x 636400.162 1372 745 543.0 1170.647094 
   
 
7 10x 646372.991 1499 662 441.6 1024.176457 
   
 
8 10x 662409.816 1520 530 348.7 800.1089163 
   
 
9 10x 648021.448 1538 294 191.2 453.6886872 
   
 
10 10x 686949.358 1385 212 153.1 308.6108132 
   
           
           
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 703084.75 1412 63 44.6 89.6051294 1600 11378 140.6223 
 
2 10x 581179.616 1378 95 68.9 163.4606538 
  
Cells/mm2 
 
3 10x 498908.544 1407 71 50.5 142.3106516 
  
319.0781 
 
4 10x 611610.013 1525 138 90.5 225.6339776 
   
 
5 10x 569845.358 1492 308 206.4 540.4975151 
   
 
6 10x 636607.989 1382 406 293.8 637.7551131 
   
 
7 10x 664924.847 1390 329 236.7 494.7927596 
   
 
8 10x 734814.429 1392 190 136.5 258.5686841 
   
           
           
           
           
           
        
Total 
  
88 
 
5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 734276.217 1589 157 98.8 213.8159951 8070 17767 454.2129 
 
2 10x 808599.549 1713 525 306.5 649.2707059 
  
Cells/mm2 
 
3 10x 862291.305 1690 791 468.0 917.3234096 
  
783.4643 
 
4 10x 964448.202 1494 965 645.9 1000.572139 
   
 
5 10x 910894.612 1393 1142 819.8 1253.712543 
   
 
6 10x 874153.659 1418 1084 764.5 1240.056584 
   
 
7 10x 823701.006 1408 960 681.8 1165.471443 
   
 
8 10x 850135.276 1409 868 616.0 1021.013978 
   
 
9 10x 802706.671 1383 846 611.7 1053.934184 
   
 
10 10x 818347.208 1376 456 331.4 557.220695 
   
 
11 10x 826360.273 1379 232 168.2 280.7492175 
   
 
12 10x 908507.053 1515 44 29.0 48.43110447 
   
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 754539.542 1376 95 69.0 125.904601 4725 16662 283.5794 
 
2 10x 699287.779 1383 320 231.4 457.6084548 
  
Cells/mm2 
 
3 10x 640268.239 1375 458 333.1 715.3251904 
  
602.7357 
 
4 10x 651579.373 1380 530 384.1 813.4081924 
   
 
5 10x 701004.451 1376 764 555.2 1089.864692 
   
 
6 10x 689902.879 1375 827 601.5 1198.71945 
   
 
7 10x 641115.736 1388 651 469.0 1015.417285 
   
 
8 10x 615337.033 1390 410 295.0 666.3015193 
   
 
9 10x 590108.105 1389 260 187.2 440.597236 
   
 
10 10x 639843.624 1387 182 131.2 284.4445005 
   
 
11 10x 528859.117 1389 174 125.3 329.0101171 
   
 
12 10x 561171.523 1454 54 37.1 96.22726348 
   
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 645034.397 1487 128 86.1 198.4390299 7667 16088 476.5664 
 
2 10x 723731.356 1400 295 210.7 407.6098093 
  
Cells/mm2 
 
3 10x 785506.995 1571 366 233.0 465.9411085 
  
858.9071 
 
4 10x 831215.747 1401 769 548.9 925.1509043 
   
 
5 10x 907150.827 1642 991 603.5 1092.431347 
   
 
6 10x 1010948.376 2044 1168 571.4 1155.350785 
   
 
7 10x 1059973.985 1865 1608 862.2 1517.018363 
   
 
8 10x 915031.217 1621 1132 698.3 1237.116263 
   
 
9 10x 780989.71 1398 831 594.4 1064.034506 
   
 
10 10x 720561.048 1659 379 228.5 525.9790285 
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One Way Analysis of Variance B4 Counts Wednesday, August 13, 2008, 11:20:19 AM 
 
Data source: Data 5 in Thesis statistics 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1 6 0 92.773 50.320 20.543  
Row 2 6 0 253.314 140.116 57.202  
Row 3 6 0 315.855 205.882 84.051  
Row 4 6 0 554.558 120.936 49.372  
Row 5 6 0 615.544 203.514 83.084  
Row 6 6 0 730.580 248.388 101.404  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 1789250.816 357850.163 11.778 <0.001  
Residual 30 911458.785 30381.959    
Total 35 2700709.600     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Row 6 vs. Row 1 637.807 6.338 0.000000544 0.003 Yes  
Row 5 vs. Row 1 522.771 5.195 0.0000134 0.004 Yes  
Row 6 vs. Row 2 477.266 4.743 0.0000482 0.004 Yes  
Row 4 vs. Row 1 461.786 4.589 0.0000742 0.004 Yes  
Row 6 vs. Row 3 414.725 4.121 0.000273 0.005 Yes  
Row 5 vs. Row 2 362.229 3.599 0.00113 0.005 Yes  
Row 4 vs. Row 2 301.244 2.993 0.00548 0.006 Yes  
Row 5 vs. Row 3 299.689 2.978 0.00570 0.006 Yes  
Row 4 vs. Row 3 238.703 2.372 0.0243 0.007 No  
Row 3 vs. Row 1 223.082 2.217 0.0344 0.009 No  
Row 6 vs. Row 4 176.021 1.749 0.0905 0.010 No  
Row 2 vs. Row 1 160.542 1.595 0.121 0.013 No  
Row 6 vs. Row 5 115.036 1.143 0.262 0.017 No  
Row 3 vs. Row 2 62.541 0.621 0.539 0.025 No  
Row 5 vs. Row 4 60.985 0.606 0.549 0.050 No  
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Bundles of 10 Microthreads - summary of attachment counts: average and standard error of mean 
Bundles of 10 EXP1 
  
Bundles of 10 EXP2 
 5h Cells/mm Cells/mm2 5h Cells/mm Cells/mm2 
slide 1 132.6702 220.5968 
 
slide 1 82.83301 165.2066 
slide 2 76.26751 135.7104 
 
slide 2 48.94239 87.95023 
slide 3 41.54896 78.06823 
 
slide 3 73.77339 162.9811 
SEM 26.55154 41.39426 
 
SEM 10.13034 25.38933 
Avg 83.49555 144.7918 
 
Avg 68.51626 138.7126 
1 day Cells/mm Cells/mm2 1 day Cells/mm Cells/mm2 
slide 1 52.23113 81.00074 
 
slide 1 92.26643 174.2227 
slide 2 106.7422 161.6459 
 
slide 2 66.58383 124.5042 
slide 3 132.0042 202.5147 
 
slide 3 83.25549 144.4171 
SEM 23.53882 35.69902 
 
SEM 7.523066 14.44689 
Avg 96.9925 148.3871 
 
Avg 80.70191 147.7147 
2 day Cells/mm Cells/mm2 2 day Cells/mm Cells/mm2 
slide 1 22.89604 38.15615 
 
slide 1 224.8517 276.1997 
slide 2 82.6929 117.5841 
 
slide 2 86.08075 116.4557 
slide 3 40.98754 84.80531 
 
SEM 69.38546 79.87197 
SEM 17.70484 23.04511 
 
Avg 155.4662 196.3277 
Avg 52.79447 77.87012 
 
3 day Cells/mm Cells/mm2 
3 day Cells/mm Cells/mm2 slide 1 87.8452 206.3944 
slide 1 90.00265 142.5531 
 
slide 2 459.3193 715.4008 
slide 2 144.7869 175.9648 
 
slide 3 398.198 461.4668 
slide 3 151.617 200.7401 
 
SEM 114.9994 146.9376 
SEM 19.49971 16.85869 
 
Avg 273.5822 460.8976 
Avg 117.3948 159.2589 
 
4 day  Cells/mm Cells/mm2 
4 day  Cells/mm Cells/mm2 slide 1 455.8665 560.4823 
slide 1 137.9041 249.7453 
 
slide 2 340.9009 792.6499 
slide 2 84.21986 163.7797 
 
slide 3 42.06479 57.74781 
slide 3 146.365 298.9086 
 
SEM 123.3225 216.8877 
SEM 19.4588 39.48766 
 
Avg 398.3837 676.5661 
Avg 111.062 206.7625 
 
5 day  Cells/mm Cells/mm2 
5 day  Cells/mm Cells/mm2 slide 1 725.4319 1095.356 
slide 1 322.485 590.6796 
 
slide 2 414.1469 656.3282 
slide 2 464.0601 641.0633 
 
slide 3 529.3692 907.0905 
slide 3 382.8681 801.1397 
 
SEM 90.86472 127.1638 
SEM 41.01611 63.44571 
 
Avg 569.7894 875.8422 
Avg 393.2726 615.8714 
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Bundle of 10 EXP1: P8 hMSCs 
   
Total 
  5h Picture # Mag Area (um2) Length (um) # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 10x 573486.241 1376 156 113.4 272.0204756 1107 8344 132.670182 
 
2 10x 929425.367 1424 289 202.9 310.9448163 
   
 
3 10x 1017985.027 1404 297 211.5 291.7528177 
  
220.596838 
 
4 10x 852444.213 1379 188 136.3 220.5422914 
   
 
5 10x 778609.666 1385 106 76.5 136.1401028 
   
 
6 10x 770227.772 1376 71 51.6 92.18052449 
   
           
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 820380.68 1386 132 95.2 160.9009125 528 6923 76.2675141 
 
2 10x 764361.776 1376 163 118.5 213.2498054 
   
 
3 10x 725645.161 1379 85 61.6 117.1371416 
  
135.710414 
 
4 10x 777068.447 1385 104 75.1 133.836344 
   
 
5 10x 823540.294 1397 44 31.5 53.42786543 
   
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 852796.566 1494 36 24.1 42.21405366 353 8496 41.5489642 
 
2 10x 700265.638 1425 61 42.8 87.10980047 
   
 
3 10x 796109.955 1421 101 71.1 126.8668974 
  
78.0682282 
 
4 10x 707991.675 1398 97 69.4 137.0072607 
   
 
5 10x 785266.505 1381 32 23.2 40.75049655 
   
 
6 10x 754479.131 1377 26 18.9 34.46086039 
   
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 10x 805302.058 1414 48 33.9 59.60496378 508 9726 52.231133 
 
2 10x 822662.736 1388 125 90.1 151.9456206 
   
 
3 10x 885622.037 1405 75 53.4 84.68623958 
  
81.0007363 
 
4 10x 877651.174 1380 84 60.9 95.71000699 
   
 
5 10x 1054583.478 1381 93 67.3 88.18647546 
   
 
6 10x 986094.057 1381 66 47.8 66.93073499 
   
 
7 10x 852510.117 1377 17 12.3 19.94111232 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 820781.015 1408 57 40.5 69.44605072 1037 9715 106.742151 
 
2 10x 724525.09 1376 212 154.1 292.6054638 
   
 
3 10x 826996.763 1376 93 67.6 112.4550955 
  
161.645927 
 
4 10x 988094.288 1387 188 135.5 190.2652432 
   
 
5 10x 926274.136 1383 147 106.3 158.7003181 
   
 
6 10x 1108703.896 1381 279 202.0 251.6451877 
   
 
7 10x 1081481.096 1404 61 43.4 56.40412969 
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Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 857060.354 1402 199 141.9 232.1890157 1503 11386 132.004216 
 
2 10x 941672.448 1392 188 135.1 199.644792 
   
 
3 10x 882962.77 1395 239 171.3 270.6795894 
  
202.514723 
 
4 10x 951382.241 1423 217 152.5 228.089185 
   
 
5 10x 919565.846 1437 176 122.5 191.3946682 
   
 
6 10x 938080.992 1429 153 107.1 163.0989236 
   
 
7 10x 992365.591 1472 205 139.3 206.577094 
   
 
8 10x 980968.32 1436 126 87.7 128.4445149 
   
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 10x 722335.53 1399 57 40.7 78.91069681 222 9696 22.8960396 
 
2 10x 812959.302 1396 54 38.7 66.42398933 
   
 
3 10x 944754.018 1386 31 22.4 32.81277392 
  
38.156151 
 
4 10x 909443.288 1380 29 21.0 31.88763982 
   
 
5 10x 891746.445 1379 21 15.2 23.54929489 
   
 
6 10x 877188.692 1376 15 10.9 17.10008364 
   
 
7 10x 914155.972 1380 15 10.9 16.40857847 
   
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 867928.084 1388 29 20.9 33.41290659 807 9759 82.6928989 
 
2 10x 1001732.57 1383 117 84.6 116.7976399 
   
 
3 10x 1023478.437 1416 183 129.2 178.8020083 
  
117.584092 
 
5 10x 1026596.716 1409 220 156.1 214.3003154 
   
 
6 10x 877970.864 1385 154 111.2 175.404454 
   
 
7 10x 996721.586 1394 82 58.8 82.26971418 
   
 
8 10x 995402.648 1384 22 15.9 22.10160888 
   
           
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 676300.15 1426 31 21.7 45.83763585 342 8344 40.987536 
 
2 10x 695126.026 1387 54 38.9 77.68375515 
   
 
3 10x 601749.335 1376 67 48.7 111.3420424 
  
84.8053118 
 
4 10x 724033.414 1380 88 63.8 121.541352 
   
 
5 10x 645905.885 1385 74 53.4 114.5677748 
   
 
6 10x 739580.298 1390 28 20.1 37.85931031 
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3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Total 
  slide 1 1 10x 1162373.396 1378 39 28.3 33.55204114 Cells Length Cells/mm 
 
2 10x 950820.615 1380 104 75.4 109.3792019 1020 11333 90.0026471 
 
3 10x 947007.747 1400 150 107.1 158.3936356 
   
 
4 10x 880867.152 1413 163 115.4 185.0449295 
  
142.553108 
 
5 10x 822747.716 1434 148 103.2 179.8850329 
   
 
6 10x 832345.936 1445 159 110.0 191.0263427 
   
 
7 10x 881220.083 1443 158 109.5 179.296867 
   
 
8 10x 953327.263 1440 99 68.8 103.8468151 
   
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 1035238.178 1376 72 52.3 69.54921247 1597 11030 144.786945 
 
2 10x 1025361.892 1376 142 103.2 138.4876902 
   
 
3 10x 1028874.147 1379 297 215.4 288.6650431 
  
200.740064 
 
4 10x 942687.016 1381 361 261.4 382.9478861 
   
 
5 10x 981614.059 1389 192 138.2 195.5962206 
   
 
6 10x 994929.472 1376 202 146.8 203.0294666 
   
 
7 10x 1006942.71 1376 245 178.1 243.3107639 
   
 
8 10x 1019751.994 1377 86 62.5 84.33423078 
   
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 
 
1287654.064 1376 93 67.6 72.22436724 1669 11008 151.617006 
 
2 
 
1162643.08 1376 174 126.5 149.6589994 
   
 
3 
 
1140030.639 1376 242 175.9 212.2749966 
  
175.964786 
 
4 
 
1215564.227 1376 316 229.7 259.9615824 
   
 
5 
 
1180943.462 1376 287 208.6 243.026029 
   
 
6 
 
1171556.249 1376 350 254.4 298.7479264 
   
 
7 
 
1196984.044 1376 180 130.8 150.3779444 
   
 
8 
 
1258950.168 1376 27 19.6 21.4464406 
   
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 
 
882244.479 1457 102 70.0 115.6142117 1941 14075 137.904085 
 
2 
 
776483.408 1476 225 152.4 289.7679431 
   
 
3 
 
686237.426 1445 300 207.6 437.16648 
  
249.745293 
 
4 
 
695920.338 1399 206 147.2 296.010892 
   
 
5 
 
868788.299 1378 197 143.0 226.7525935 
   
 
6 
 
873348.942 1380 256 185.5 293.1245321 
   
 
7 
 
826005.608 1383 306 221.3 370.4575333 
   
 
8 
 
772233.206 1396 200 143.3 258.989122 
   
 
9 
 
691669.557 1385 101 72.9 146.0234862 
   
 
10 
 
755356.689 1376 48 34.9 63.54613747 
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Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 
 
711114.002 1376 51 37.1 71.71845844 1045 12408 84.2198582 
 
2 
 
686662.909 1378 161 116.8 234.4673025 
   
 
3 
 
693327.552 1376 251 182.4 362.0222495 
  
163.779654 
 
4 
 
834686.091 1376 227 165.0 271.9585272 
   
 
5 
 
749999.422 1378 139 100.9 185.3334762 
   
 
6 
 
634427.68 1377 50 36.3 78.81118932 
   
 
7 
 
640976.413 1378 82 59.5 127.9298245 
   
 
8 
 
612359.521 1379 59 42.8 96.3486285 
   
 
9 
 
550330.674 1390 25 18.0 45.42723345 
   
           
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 
 
650811.944 1449 84 58.0 129.0695427 2271 15516 146.365043 
 
2 
 
634268.991 1413 170 120.3 268.0250846 
   
 
3 
 
646387.444 1412 253 179.2 391.4061177 
  
298.908597 
 
4 
 
680924.384 1394 369 264.7 541.9103922 
   
 
5 
 
672099.665 1384 339 244.9 504.3894792 
   
 
6 
 
683183.316 1379 299 216.8 437.6570578 
   
 
7 
 
712095.04 1377 240 174.3 337.0336634 
   
 
8 
 
714936.987 1383 145 104.8 202.8150769 
   
 
9 
 
748172.621 1420 164 115.5 219.2007505 
   
 
10 
 
833872.991 1450 163 112.4 195.4734135 
   
 
11 
 
737535.842 1455 45 30.9 61.01398391 
   
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 
 
836201.873 1376 310 225.3 370.7238766 4895 15179 322.485012 
 
2 
 
828125.795 1376 425 308.9 513.2070545 
   
 
3 
 
798590.589 1401 577 411.8 722.5229147 
  
590.679625 
 
4 
 
753418.314 1382 552 399.4 732.6607142 
   
 
5 
 
703310.209 1376 434 315.4 617.0818999 
   
 
6 
 
685224.303 1376 499 362.6 728.2286951 
   
 
7 
 
685577.523 1376 564 409.9 822.6640768 
   
 
8 
 
770446.294 1386 537 387.4 696.9986152 
   
 
9 
 
827493.352 1382 405 293.1 489.4299139 
   
 
10 
 
752504.914 1376 291 211.5 386.7084382 
   
 
11 
 
721390.623 1372 301 219.4 417.2496708 
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Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 
 
1017988.207 1391 314 225.7 308.4515104 5804 12507 464.060126 
 
2 
 
1205187.594 1469 886 603.1 735.1552608 
   
 
3 
 
870039.6 1418 927 653.7 1065.468744 
  
641.063273 
 
4 
 
1149344.144 1406 1121 797.3 975.3388538 
   
 
5 
 
1139360.62 1585 1109 699.7 973.3529319 
   
 
6 
 
858405.307 1385 791 571.1 921.4761297 
   
 
7 
 
793212.799 1393 440 315.9 554.7061275 
   
 
8 
 
902423.112 1393 164 117.7 181.7329342 
   
 
9 
 
964982.946 1067 52 48.7 53.88696268 
   
           
           
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 
 
594987.86 1376 256 186.0 430.2608796 5815 15188 382.868054 
 
2 
 
582079.431 1381 279 202.0 479.3160265 
   
 
3 
 
632249.393 1388 396 285.3 626.3351209 
  
801.13975 
 
4 
 
623344.317 1376 665 483.3 1066.826121 
   
 
5 
 
685505.839 1376 847 615.6 1235.583932 
   
 
6 
 
681261.418 1376 857 622.8 1257.960567 
   
 
7 
 
701696.15 1376 790 574.1 1125.84343 
   
 
8 
 
645911.955 1381 800 579.3 1238.558899 
   
 
9 
 
639114.348 1383 514 371.7 804.2379296 
   
 
10 
 
748979.651 1383 339 245.1 452.6157681 
   
 
11 
 
757906.116 1392 72 51.7 94.99857368 
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Bundle of 10 EXP2: P7 hMSCs 
        
Total 
  5h Picture # Mag Area (um2) Length (um) # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 705035.264 1408 24 17.0 34.0408505 814 9827 82.83301 
 
2 10x 705035.264 1424 141 99.0 199.989997 
   
 
3 10x 718884.264 1419 206 145.2 286.555167 
  
165.2066 
 
4 10x 683346.052 1420 176 123.9 257.556182 
   
 
5 10x 726209.966 1397 117 83.8 161.11043 
   
 
6 10x 670505.261 1382 110 79.6 164.055387 
   
 
7 10x 752755.81 1377 40 29.0 53.1380821 
   
           
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 747590.473 1481 43 29.0 57.518122 435 8888 48.94239 
 
2 10x 840009.25 1477 87 58.9 103.570288 
   
 
3 10x 868044.861 1477 99 67.0 114.049405 
  
87.95023 
 
4 10x 783540.872 1522 88 57.8 112.31067 
   
 
5 10x 845541.681 1475 91 61.7 107.623317 
   
 
6 10x 827470.228 1456 27 18.5 32.6295727 
   
           
        
Total 
  5h Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 631748.468 1402 31 22.1 49.0701625 627 8499 73.77339 
 
2 10x 647567.638 1419 99 69.8 152.879783 
   
 
3 10x 703413.978 1432 197 137.6 280.062675 
  
162.9811 
 
4 10x 635296.566 1443 139 96.3 218.795453 
   
 
5 10x 577743.67 1429 96 67.2 166.163655 
   
 
6 10x 586035.38 1374 65 47.3 110.914805 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 719110.302 1373 78 56.8 108.467366 1032 11185 92.26643 
 
2 10x 791743.554 1374 193 140.5 243.765799 
   
 
3 10x 810563.36 1386 100 72.2 123.370985 
  
174.2227 
 
4 10x 657710.14 1376 86 62.5 130.756689 
   
 
5 10x 663487.686 1376 192 139.5 289.3799 
   
 
6 10x 776806.567 1410 293 207.8 377.185277 
   
 
7 10x 743706.787 1431 72 50.3 96.8123476 
   
 
8 10x 748644.352 1459 18 12.3 24.0434593 
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Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 726142.329 1381 14 10.1 19.2799668 643 9657 66.58383 
 
2 10x 751413.458 1376 65 47.2 86.503641 
   
 
3 10x 759849.116 1376 113 82.1 148.713735 
  
124.5042 
 
4 10x 726000.694 1380 129 93.5 177.685781 
   
 
5 10x 752047.636 1376 158 114.8 210.093074 
   
 
6 10x 721771.881 1376 145 105.4 200.894498 
   
 
7 10x 669984.68 1392 19 13.6 28.3588574 
   
           
        
Total 
  1 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 849481.732 1447 96 66.3 113.010082 713 8564 83.25549 
 
2 10x 861389.756 1451 133 91.7 154.40165 
   
 
3 10x 833967.222 1429 120 84.0 143.890547 
  
144.4171 
 
4 10x 814666.435 1417 181 127.7 222.176823 
   
 
5 10x 787786.449 1402 136 97.0 172.635617 
   
 
6 10x 778302.983 1418 47 33.1 60.3877937 
   
           
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 4 1 10x 1273765.75 1376 32 23.3 25.1223586 3411 15170 224.8517 
 
2 10x 1275572.32 1376 65 47.2 50.9575184 
   
 
3 10x 1095278.07 1376 100 72.7 91.3010157 
  
276.1997 
 
4 10x 1058494.62 1376 215 156.3 203.118651 
   
 
5 10x 1254062.32 1410 278 197.2 221.679573 
   
 
6 10x 1178662.85 1376 251 182.4 212.953178 
   
 
7 10x 1243384.21 1376 725 526.9 583.086062 
   
 
8 10x 1308792.92 1376 478 347.4 365.222023 
   
 
9 10x 1220331.83 1376 441 320.5 361.377118 
   
 
10 10x 1111685.74 1376 479 348.1 430.877163 
   
 
11 10x 704565.846 1376 347 252.2 492.501875 
   
        
Total 
  2 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 674355.995 1397 33 23.6 48.9355774 953 11071 86.08075 
 
2 10x 955764.828 1376 37 26.9 38.712452 
   
 
3 10x 927340.444 1418 121 85.3 130.480667 
  
116.4557 
 
4 10x 1022203.15 1376 126 91.6 123.26317 
   
 
5 10x 1119011.74 1376 168 122.1 150.132474 
   
 
6 10x 1277288.7 1376 234 170.1 183.200555 
   
 
7 10x 925284.715 1376 178 129.4 192.37322 
   
 
8 10x 867573.13 1376 56 40.7 64.5478728 
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Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 10x 557182.333 1376 85 61.8 152.553294 967 11008 87.8452 
 
2 10x 606253.324 1376 91 66.1 150.10227 
   
 
3 10x 680332.986 1376 152 110.5 223.420006 
  
206.3944 
 
4 10x 568771.534 1376 115 83.6 202.190147 
   
 
5 10x 639597.641 1376 111 80.7 173.546606 
   
 
6 10x 532167.592 1376 170 123.5 319.448239 
   
 
7 10x 581637.183 1376 148 107.6 254.454159 
   
 
8 10x 541495.26 1376 95 69.0 175.440132 
   
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 5 1 10x 895634.177 1376 15 10.9 16.7479093 12307 26794 459.3193 
 
2 10x 1166156.49 1517 70 46.1 60.026249 
   
 
3 10x 1137993.12 1463 542 370.5 476.277044 
  
715.4008 
 
4 10x 992255.174 1437 933 649.3 940.282323 
   
 
5 10x 1182993.99 1388 1198 863.1 1012.68477 
   
 
6 10x 1133091.69 1386 1595 1150.8 1407.65308 
   
 
7 10x 1043905.65 1376 1715 1246.4 1642.86877 
   
 
8 10x 1173916.06 1419 1324 933.1 1127.84895 
   
 
9 10x 1145649.79 1452 508 349.9 443.416484 
   
 
10 10x 1183094 1376 31 22.5 26.2024827 
   
           
        
Total 
  3 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 6 1 10x 951719.563 1445 136 94.1 142.899238 9458 23752 398.198 
 
2 10x 1050765.99 1417 497 350.7 472.988284 
   
 
3 10x 1093279.86 1376 642 466.6 587.223843 
  
461.4668 
 
4 10x 1012958.72 1376 691 502.2 682.160076 
   
 
5 10x 1071396.12 1388 715 515.1 667.353549 
   
 
6 10x 1040496.88 1390 625 449.6 600.674556 
   
 
7 10x 1104450.23 1392 559 401.6 506.134172 
   
 
8 10x 1026104.75 1416 378 266.9 368.383442 
   
 
9 10x 1060740.55 1404 133 94.7 125.384101 
   
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 10x 996385.131 1376 239 173.7 239.867088 5082 11148 455.8665 
 
2 10x 1176705.4 1406 782 556.2 664.56736 
   
 
3 10x 1174134 1391 931 669.3 792.924825 
  
560.4823 
 
4 10x 1112743.67 1396 1116 799.4 1002.9264 
   
 
5 10x 1080062.44 1408 837 594.5 774.9552 
   
 
6 10x 1186984.91 1414 715 505.7 602.366545 
   
 
7 10x 1230558.45 1381 389 281.7 316.116639 
   
 
8 10x 809902.59 1376 73 53.1 90.1342963 
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Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 10x 657344.202 1409 244 173.2 371.190617 3784 11100 340.9009 
 
2 10x 656931.437 1403 469 334.3 713.925341 
   
 
3 10x 624276.217 1385 569 410.8 911.455514 
  
792.6499 
 
4 10x 587960.458 1376 721 524.0 1226.27294 
   
 
5 10x 597835.01 1376 732 532.0 1224.41809 
   
 
6 10x 557872.008 1389 611 439.9 1095.2333 
   
 
7 10x 549718.465 1386 354 255.4 643.965998 
   
 
8 10x 542854.087 1376 84 61.0 154.737713 
   
           
        
Total 
  4 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 
 
1053118.57 1480 44 29.7 41.7806706 361 8582 42.06479 
 
2 
 
1055120.53 1501 48 32.0 45.4924328 
   
 
3 
 
1082718.81 1411 83 58.8 76.6588695 
  
57.74781 
 
4 
 
1075227.77 1404 97 69.1 90.2134436 
   
 
5 
 
990624.35 1379 57 41.3 57.5394699 
   
 
6 
 
919488.38 1407 32 22.7 34.8019624 
   
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 1 1 
 
739875.708 1402 294 209.7 397.364039 9028 12445 725.4319 
 
2 
 
819817.32 1382 752 544.1 917.277522 
   
 
3 
 
844398.196 1387 1219 878.9 1443.6317 
  
1095.356 
 
4 
 
929880.911 1385 1398 1009.4 1503.41832 
   
 
5 
 
1023275.52 1378 1572 1140.8 1536.24314 
   
 
6 
 
1014286.05 1377 1469 1066.8 1448.30939 
   
 
7 
 
930631.287 1380 1446 1047.8 1553.784 
   
 
8 
 
834101.052 1378 754 547.2 903.967209 
   
 
9 
 
804090.646 1376 124 90.1 154.211469 
   
           
        
Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 2 1 
 
791387.444 1376 188 136.6 237.557471 4602 11112 414.1469 
 
2 
 
844701.7 1378 439 318.6 519.710094 
   
 
3 
 
786546.422 1376 504 366.3 640.775911 
  
656.3282 
 
4 
 
821723.899 1376 634 460.8 771.548693 
   
 
5 
 
934968.783 1376 668 485.5 714.462357 
   
 
6 
 
994705.457 1404 992 706.6 997.280143 
   
 
7 
 
875953.289 1426 874 612.9 997.770099 
   
 
8 
 
815567.407 1400 303 216.4 371.520487 
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Total 
  5 Day Picture # Mag Area (um2) Length # Cells cells/mm cells/mm2 Cells Length Cells/mm 
slide 3 1 
 
862444.213 1380 233 168.8 270.162402 5849 11049 529.3692 
 
2 
 
790865.996 1380 654 473.9 826.94161 
   
 
3 
 
800280.09 1383 935 676.1 1168.34095 
  
907.0905 
 
4 
 
784104.81 1379 1135 823.1 1447.51057 
   
 
5 
 
783920.684 1386 1168 842.7 1489.94665 
   
 
6 
 
879078.506 1385 895 646.2 1018.11157 
   
 
7 
 
821203.896 1380 655 474.6 797.609465 
   
 
8 
 
730782.749 1376 174 126.5 238.100859 
    
 
 
One Way Analysis of Variance B10 Counts Wednesday, August 13, 2008, 1:37:27 PM 
 
Data source: Data 6 in Thesis statistics 
 
Normality Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Wednesday, August 13, 2008, 1:37:27 PM 
 
Data source: Data 6 in Thesis statistics 
 
Group N  Missing  Median    25%      75%     
5 hour 6 0 149.346 87.950 165.207  
1 day 6 0 153.032 124.504 174.223  
2 day 5 0 116.456 73.143 157.238  
3 day 6 0 203.567 175.965 461.467  
4 day 6 0 274.327 163.780 560.482  
5 day 6 0 728.734 641.063 907.091  
 
H = 19.094 with 5 degrees of freedom.  (P = 0.002) 
 
The differences in the median values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = 0.002) 
 
To isolate the group or groups that differ from the others use a multiple comparison procedure. 
 
 
All Pairwise Multiple Comparison Procedures (Dunn's Method) : 
 
Comparison Diff of Ranks Q P<0.05   
5 day vs 2 day 22.500 3.626 Yes   
5 day vs 5 hour 19.667 3.324 Yes   
5 day vs 1 day 19.000 3.212 Yes   
5 day vs 4 day 10.833 1.831 No   
5 day vs 3 day 10.500 1.775 Do Not Test   
3 day vs 2 day 12.000 1.934 No   
3 day vs 5 hour 9.167 1.549 Do Not Test   
3 day vs 1 day 8.500 1.437 Do Not Test   
3 day vs 4 day 0.333 0.0563 Do Not Test   
4 day vs 2 day 11.667 1.880 Do Not Test   
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4 day vs 5 hour 8.833 1.493 Do Not Test   
4 day vs 1 day 8.167 1.380 Do Not Test   
1 day vs 2 day 3.500 0.564 Do Not Test   
1 day vs 5 hour 0.667 0.113 Do Not Test   
5 hour vs 2 day 2.833 0.457 Do Not Test   
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Appendix C: Cells per Microthread Calculations 
Surface area of microthread bundle was calculated based on bundle circumference 
estimations 
Total thread surface area (B4): 
Individual diameter (um) 100 
Circumference of thread (um) 942.477796 
Thread length (2cm) 20000 
Bundle SA (um2) 18849555.9 
Bundle SA (mm2) 18.8495559 
Unseeded ends were accounted for by measuring the area of several samples, averaging 
the total unseeded area per thread and multiplying that by two to account for the 
opposite face. 
 
area um2 mm2 
  
area um2 mm2 
5h s1 pic 1 1010797 1.010797 
 
day 1 s1 pic 1 1045188.437 1.04518844 
 
pic2 1070965 1.070965 
  
pic2 683992.322 0.68399232 
 
pic3 896036.7 0.896037 
    
1.72918076 
   
2.977799 
     5h s1 
    
day 1 s1 pic 3 1172643.899 1.1726439 
 
pic 4 1204654 1.204654 
  
pic 4 854020.404 0.8540204 
 
pic5 1197990 1.19799 
  
pic 5 790495.594 0.79049559 
 
pic 6 245155.6 0.245156 
    
2.8171599 
   
2.6478 
 
day 1 s2 
   5h s2 
     
pic 1 1205911.302 1.2059113 
 
pic 1 1305631 1.305631 
  
pic2 681317.028 0.68131703 
 
pic2 634378.1 0.634378 
    
1.88722833 
   
1.940009 
 
day 1 s2 
   
      
pic 3 830106.032 0.83010603 
      
pic4 699114.611 0.69911461 
      
pic5 488916.308 0.48891631 
      
pic6 595567.689 0.59556769 
        
2.61370464 
         
 
per end 2.521869 
      
  
avg stdev 
  
per end 2.261818407 
 
 
per thread 3.782804 2.606106 
   
avg stdev 
 
both sides 7.565608 5.212211 
  
per thread 4.523636813 0.03210808 
      
both sides 9.047273626 0.06421617 
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area um2 mm2 
   
area um2 mm2 
day 2 s1 pic 1 1418447 1.418447 
  
day 3 s1 pic 1 665735.3 0.665735 
 
pic2 819888.8 0.819889 
   
pic2 1159634 1.159634 
   
2.238336 
     
1.825369 
          day 2 s1 pic 3 1272121 1.272121 
  
day 3 s1 pic 3 1339989 1.339989 
 
pic 4 573456.3 0.573456 
      
   
1.845577 
     
1.339989 
          day 2 s2 pic 1 1613413 1.613413 
  
day 3 s2 pic 1 606162.7 0.606163 
 
pic2 635061.5 0.635062 
   
pic2 286125.8 0.286126 
   
2.248475 
     
0.892289 
          day 2 s2 pic 3 1337684 1.337684 
  
day 3 s2 pic 3 1504954 1.504954 
 
pic4 995484.4 0.995484 
   
pic4 602435.5 0.602436 
   
2.333169 
     
2.10739 
          day 2 s3 pic 1 617506.5 0.617506 
  
day 3 s3 pic 1 786953.8 0.786954 
   
0 
   
pic2 286673.9 0.286674 
   
0.617506 
     
1.073628 
          day 2 s3 pic2 619024.9 0.619025 
  
day 3 s3 pic 3 392630.2 0.39263 
 
pic3 372896.7 0.372897 
     
0 
   
0.991922 
     
0.39263 
 
per end 1.712497 
       
  
avg stdev 
  
day 3 s4 pic 1 649832.8 0.649833 
 
per thread 3.424995 1.5919 
   
pic2 440891.6 0.440892 
 
both sides 6.849989 3.1838 
     
1.090724 
          
      
day 3 s4 pic4 779296.4 0.779296 
       
pic5 154643.4 0.154643 
         
0.93394 
          
       
per end 1.206995 
 
        
avg stdev 
       
per thread 2.413989 0.807745 
       
both sides 4.827979 1.615489 
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area um2 mm2 
   
area um2 mm2 
day 4 s1 pic 1 1145581 1.145581 
  
day 5 s1 pic 1 928116.9 0.928117 
         
0 
   
1.145581 
     
0.928117 
          
      
day 5 s1 pic2 1015805 1.015805 
day 4 s2 pic 1 936801.7 0.936802 
      
         
1.015805 
   
0.936802 
      
      
day 5 s2 pic 1 735711.6 0.735712 
         
0 
day 4 s3 pic 1 319533.1 0.319533 
     
0.735712 
 
pic2 - 
       
   
0.319533 
  
day 5 s2 pic2 441793.1 0.441793 
         
0 
day 4 s3 pic 3 351034.9 0.351035 
     
0.441793 
 
pic4 310387.7 0.310388 
      
   
0.661423 
      
       
per end 0.780357 
 day 4 s3 pic 1 631118.5 0.631119 
    
avg stdev 
   
0.631119 
   
per thread 1.560713 0.541939 
       
both sides 3.121426 1.083877 
day 4 s3 pic2 631223.5 0.631223 
      
 
pic 3 283533.3 0.283533 
      
 
pic4 138901.8 0.138902 
      
   
1.053659 
      
          
 
per end 0.791353 
       
  
avg stdev 
      
 
per thread 1.187029 0.343779 
      
 
both sides 2.374058 0.687557 
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Time Point Unseeded area Average (mm2) Stdev 
5 hours 7.565608 5.212211 
1 day 9.047274 0.064216 
2 day 6.849989 3.1838 
3 day 4.827979 1.615489 
4 day 2.374058 0.687557 
5 day 3.121426 1.083877 
   
Average 5.631056  
 
SEM 1.071604 
 
 
The average unseeded area per microthread bundle is 5.6 + 1.1 mm2. Subtracting this 
from the total surface area of a microthread bundle (18.8 mm2) leaves 13.2 mm2 as the 
average cell populated surface area of all microthread bundles.  
 
 
One Way Analysis of Variance B4 Total Cells/Bundle Thursday, August 28, 2008, 1:37:40 PM 
 
Data source: Data 7 in Thesis statistics 
 
Normality Test: Passed (P = 0.847) 
 
Equal Variance Test: Passed (P = 0.446) 
 
Group Name  N  Missing Mean Std Dev SEM  
5 hour 6 0 1224.598 664.219 271.166  
1 day 6 0 3343.748 1849.528 755.067  
2 day 6 0 4169.287 2717.643 1109.473  
3 day 6 0 7320.172 1596.351 651.708  
4 day 6 0 8125.178 2686.388 1096.713  
5 day 6 0 9643.654 3278.715 1338.530  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 311759062.104 62351812.421 11.778 <0.001  
Residual 30 158812578.661 5293752.622    
Total 35 470571640.765     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
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Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
5 day vs. 5 hour 8419.056 6.338 0.000000544 0.003 Yes  
4 day vs. 5 hour 6900.579 5.195 0.0000134 0.004 Yes  
5 day vs. 1 day 6299.906 4.743 0.0000482 0.004 Yes  
3 day vs. 5 hour 6095.574 4.589 0.0000742 0.004 Yes  
5 day vs. 2 day 5474.367 4.121 0.000273 0.005 Yes  
4 day vs. 1 day 4781.429 3.599 0.00113 0.005 Yes  
3 day vs. 1 day 3976.424 2.993 0.00548 0.006 Yes  
4 day vs. 2 day 3955.891 2.978 0.00570 0.006 Yes  
3 day vs. 2 day 3150.885 2.372 0.0243 0.007 No  
2 day vs. 5 hour 2944.689 2.217 0.0344 0.009 No  
5 day vs. 3 day 2323.482 1.749 0.0905 0.010 No  
1 day vs. 5 hour 2119.150 1.595 0.121 0.013 No  
5 day vs. 4 day 1518.476 1.143 0.262 0.017 No  
2 day vs. 1 day 825.538 0.621 0.539 0.025 No  
4 day vs. 3 day 805.006 0.606 0.549 0.050 No  
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Appendix D: CyQuant Standard Curve Data 
Fluorescence versus time 
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One Way Analysis of Variance 50,000 cells Monday, August 11, 2008, 8:24:05 AM 
 
Data source: Data 3 in Notebook 1 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1(30min) 5 0 668907.200 46237.743 20678.147  
Row 2(40min) 5 0 1388193.800 83171.874 37195.593  
Row 3(50min) 5 0 1555962.000 258221.828 115480.312  
Row 4(60min) 5 0 1564547.800 262671.193 117470.129  
Row 5(70min) 5 0 1473916.200 239805.389 107244.230  
Row 6(80min) 5 0 1382146.000 257400.936 115113.198  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 2.847E+012 569452650616.059 12.726 <0.001  
Residual 24 1.074E+012 44748670608.217    
Total 29 3.921E+012     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Row 4 vs. Row 1 895640.600 6.694 0.000000634 0.003 Yes  
Row 3 vs. Row 1 887054.800 6.630 0.000000739 0.004 Yes  
Row 5 vs. Row 1 805009.000 6.017 0.00000327 0.004 Yes  
Row 2 vs. Row 1 719286.600 5.376 0.0000161 0.004 Yes  
Row 6 vs. Row 1 713238.800 5.331 0.0000180 0.005 Yes  
Row 4 vs. Row 6 182401.800 1.363 0.185 0.005 No  
Row 4 vs. Row 2 176354.000 1.318 0.200 0.006 No  
Row 3 vs. Row 6 173816.000 1.299 0.206 0.006 No  
Row 3 vs. Row 2 167768.200 1.254 0.222 0.007 No  
Row 5 vs. Row 6 91770.200 0.686 0.499 0.009 No  
Row 4 vs. Row 5 90631.600 0.677 0.505 0.010 No  
Row 5 vs. Row 2 85722.400 0.641 0.528 0.013 No  
Row 3 vs. Row 5 82045.800 0.613 0.545 0.017 No  
Row 4 vs. Row 3 8585.800 0.0642 0.949 0.025 No  
Row 2 vs. Row 6 6047.800 0.0452 0.964 0.050 No  
 
One Way Analysis of Variance 30,000 cells Monday, August 11, 2008, 8:29:07 AM 
 
Data source: Data 3 in Notebook 1 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1 5 0 431579.800 22976.984 10275.619  
Row 2 5 0 708628.600 96896.302 43333.344  
Row 3 5 0 843818.400 184638.511 82572.852  
Row 4 5 0 929092.200 167858.663 75068.676  
Row 5 5 0 951598.400 207141.810 92636.634  
Row 6 5 0 964567.400 251472.923 112462.110  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 1.063E+012 212588595558.880 7.153 <0.001  
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Residual 24 713324425166.401 29721851048.600    
Total 29 1.776E+012     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 0.986 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Row 6 vs. Row 1 532987.600 4.888 0.0000552 0.003 Yes  
Row 5 vs. Row 1 520018.600 4.769 0.0000747 0.004 Yes  
Row 4 vs. Row 1 497512.400 4.563 0.000126 0.004 Yes  
Row 3 vs. Row 1 412238.600 3.781 0.000915 0.004 Yes  
Row 2 vs. Row 1 277048.800 2.541 0.0179 0.005 No  
Row 6 vs. Row 2 255938.800 2.347 0.0275 0.005 No  
Row 5 vs. Row 2 242969.800 2.228 0.0355 0.006 No  
Row 4 vs. Row 2 220463.600 2.022 0.0545 0.006 No  
Row 3 vs. Row 2 135189.800 1.240 0.227 0.007 No  
Row 6 vs. Row 3 120749.000 1.107 0.279 0.009 No  
Row 5 vs. Row 3 107780.000 0.988 0.333 0.010 No  
Row 4 vs. Row 3           85273.800          0.782 0.442                      0.013            No  
 
One Way Analysis of Variance 10,000 cells Monday, August 11, 2008, 8:30:12 AM 
 
Data source: Data 3 in Notebook 1 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1 5 0 148055.000 18920.072 8461.313  
Row 2 5 0 223571.600 47322.078 21163.077  
Row 3 5 0 286146.600 100081.101 44757.629  
Row 4 5 0 268299.800 33668.409 15056.970  
Row 5 5 0 269442.600 36049.969 16122.036  
Row 6 5 0 264800.600 41615.477 18611.007  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 65336539239.366 13067307847.873 4.673 0.004  
Residual 24 67114340037.600 2796430834.900    
Total 29 132450879276.967     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = 0.004). 
 
Power of performed test with alpha = 0.050: 0.862 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Row 3 vs. Row 1 138091.600 4.129 0.000380 0.003 Yes  
Row 5 vs. Row 1 121387.600 3.629 0.00134 0.004 Yes  
Row 4 vs. Row 1 120244.800 3.595 0.00145 0.004 Yes  
Row 6 vs. Row 1 116745.600 3.491 0.00189 0.004 Yes  
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Row 2 vs. Row 1 75516.600 2.258 0.0333 0.005 No  
Row 3 vs. Row 2 62575.000 1.871 0.0736 0.005 No  
Row 5 vs. Row 2 45871.000 1.372 0.183 0.006 No  
Row 4 vs. Row 2 44728.200 1.337 0.194 0.006 No  
Row 6 vs. Row 2 41229.000 1.233 0.230 0.007 No  
Row 3 vs. Row 6 21346.000 0.638 0.529 0.009 No  
Row 3 vs. Row 4 17846.800 0.534 0.599 0.010 No  
Row 3 vs. Row 5 16704.000 0.499 0.622 0.013 No  
Row 5 vs. Row 6 4642.000 0.139 0.891 0.017 No  
One Way Analysis of Variance 5,000 cells Monday, August 11, 2008, 8:31:31 AM 
 
Data source: Data 3 in Notebook 1 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1 5 0 65040.200 5385.951 2408.670  
Row 2 5 0 81551.800 7859.450 3514.853  
Row 3 5 0 86100.400 7004.436 3132.479  
Row 4 5 0 93000.200 10136.731 4533.284  
Row 5 5 0 95767.000 12295.574 5498.748  
Row 6 5 0 95760.200 10490.365 4691.434  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 3492601935.900 698520387.180 8.319 <0.001  
Residual 24 2015294958.400 83970623.267    
Total 29 5507896894.300     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 0.996 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Row 5 vs. Row 1 30726.800 5.302 0.0000194 0.003 Yes  
Row 6 vs. Row 1 30720.000 5.301 0.0000194 0.004 Yes  
Row 4 vs. Row 1 27960.000 4.824 0.0000649 0.004 Yes  
Row 3 vs. Row 1 21060.200 3.634 0.00132 0.004 Yes  
Row 2 vs. Row 1 16511.600 2.849 0.00886 0.005 No  
Row 5 vs. Row 2 14215.200 2.453 0.0218 0.005 No  
Row 6 vs. Row 2 14208.400 2.452 0.0219 0.006 No  
Row 4 vs. Row 2 11448.400 1.975 0.0598 0.006 No  
Row 5 vs. Row 3 9666.600 1.668 0.108 0.007 No  
Row 6 vs. Row 3 9659.800 1.667 0.109 0.009 No  
Row 4 vs. Row 3 6899.800 1.191 0.245 0.010 No  
Row 3 vs. Row 2 4548.600 0.785 0.440 0.013 No  
Row 5 vs. Row 4 2766.800 0.477 0.637 0.017 No  
Row 6 vs. Row 4 2760.000 0.476 0.638 0.025 No  
Row 5 vs. Row 6 6.800 0.00117 0.999 0.050 No  
 
 
One Way Analysis of Variance 1.000 cells Monday, August 11, 2008, 8:32:22 AM 
 
Data source: Data 3 in Notebook 1 
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Group Name  N  Missing Mean Std Dev SEM  
Row 1 5 0 20920.800 3394.390 1518.017  
Row 2 5 0 23976.200 2266.069 1013.417  
Row 3 5 0 24215.000 1822.671 815.123  
Row 4 5 0 23853.200 4213.589 1884.374  
Row 5 5 0 21978.200 3389.609 1515.879  
Row 6 5 0 25628.400 4316.323 1930.318  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 71652084.567 14330416.913 1.267 0.310  
Residual 24 271414048.400 11308918.683    
Total 29 343066132.967     
 
The differences in the mean values among the treatment groups are not great enough to exclude the possibility that the difference is 
due to random sampling variability; there is not a statistically significant difference  (P = 0.310). 
 
Power of performed test with alpha = 0.050: 0.102 
 
The power of the performed test (0.102) is below the desired power of 0.800. 
Less than desired power indicates you are more likely to not detect a difference when one actually exists. Be cautious in over-
interpreting the lack of difference found here. 
 
One Way Analysis of Variance 500 cells Monday, August 11, 2008, 8:33:29 AM 
 
Data source: Data 3 in Notebook 1 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1 5 0 13394.400 815.016 364.486  
Row 2 5 0 15535.600 1236.662 553.052  
Row 3 5 0 16742.400 1205.125 538.948  
Row 4 5 0 14750.400 1130.662 505.647  
Row 5 5 0 14553.400 826.660 369.694  
Row 6 5 0 14394.200 1177.491 526.590  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 32317279.067 6463455.813 5.545 0.002  
Residual 24 27976626.800 1165692.783    
Total 29 60293905.867     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = 0.002). 
 
Power of performed test with alpha = 0.050: 0.934 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
Row 3 vs. Row 1 3348.000 4.903 0.0000532 0.003 Yes  
Row 3 vs. Row 6 2348.200 3.439 0.00214 0.004 Yes  
Row 3 vs. Row 5 2189.000 3.206 0.00379 0.004 Yes  
Row 2 vs. Row 1 2141.200 3.136 0.00449 0.004 No  
Row 3 vs. Row 4 1992.000 2.917 0.00755 0.005 No  
Row 4 vs. Row 1 1356.000 1.986 0.0586 0.005 No  
Row 3 vs. Row 2 1206.800 1.767 0.0899 0.006 No  
Row 5 vs. Row 1 1159.000 1.697 0.103 0.006 No  
Row 2 vs. Row 6 1141.400 1.672 0.108 0.007 No  
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Row 6 vs. Row 1 999.800 1.464 0.156 0.009 No  
Row 2 vs. Row 5 982.200 1.438 0.163 0.010 No  
Row 2 vs. Row 4 785.200 1.150 0.262 0.013 No  
Row 4 vs. Row 6 356.200 0.522 0.607 0.017 No  
Row 4 vs. Row 5 197.000 0.288 0.775 0.025 No  
Row 5 vs. Row 6 159.200 0.233 0.818 0.050 No  
 
 
One Way Analysis of Variance 100 cells Monday, August 11, 2008, 8:35:14 AM 
 
Data source: Data 3 in Notebook 1 
 
Group Name  N  Missing Mean Std Dev SEM  
Row 1 5 0 7460.000 413.970 185.133 
Row 2 5 0 8099.000 1025.907 458.800 
Row 3 5 0 7527.400 110.972 49.628 
Row 4 5 0 7537.800 381.481 170.603 
Row 5 5 0 7172.600 225.546 100.867 
Row 6 5 0 7426.400 456.656 204.223 
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 5 2334426.400 466885.280 1.707 0.171  
Residual 24 6564416.400 273517.350    
Total 29 8898842.800     
 
The differences in the mean values among the treatment groups are not great enough to exclude the possibility that the difference is 
due to random sampling variability; there is not a statistically significant difference  (P = 0.171). 
 
Power of performed test with alpha = 0.050: 0.209 
 
The power of the performed test (0.209) is below the desired power of 0.800. 
Less than desired power indicates you are more likely to not detect a difference when one actually exists. Be cautious in over-
interpreting the lack of difference found here. 
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Standard Curve: Plated hMSCs 
Well #Cells 60min corrected Average Stdev 
A01 50000 1551097 1543993 
  A02 50000 1576900 1569796 
  A03 50000 1257113 1250009 
  A04 50000 1460417 1453313 
  A05 50000 1977212 1970108 1557444 262671 
B01 30000 800932 793828 
  B02 30000 995125 988021 
  B03 30000 953864 946760 
  B04 30000 734921 727817 
  B05 30000 1160619 1153515 921988 167859 
C01 10000 271072 263968 
  C02 10000 227951 220847 
  C03 10000 264324 257220 
  C04 10000 320852 313748 
  C05 10000 257300 250196 261196 33668 
D01 5000 99112 92008 
  D02 5000 101169 94065 
  D03 5000 83273 76169 
  D04 5000 100772 93668 
  D05 5000 80675 73571 85896 10137 
E01 1000 22911 15807 
  E02 1000 29936 22832 
  E03 1000 25993 18889 
  E04 1000 21225 14121 
  E05 1000 19201 12097 16749 4214 
F01 500 13821 6717 
  F02 500 16721 9617 
  F03 500 14462 7358 
  F04 500 14372 7268 
  F05 500 14376 7272 7646 1131 
G01 100 7775 671 
  G02 100 8097 993 
  G03 100 7304 200 
  G04 100 7246 142 
  G05 100 7267 163 434 381 
      H01 0 7192 
   H02 0 6914 
   H03 0 7105 
   H04 0 7152 
   H05 0 7157 7104 
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Standard Curve: Microthreads (Digested/Re-plated) 
Well #Cells 60min corrected Average Stdev 
A01 50000 463496 457672 
  A02 50000 449118 449118 
  A03 50000 468653 468653 
  A04 50000 553448 553448 
  A05 50000 372212 372212 460221 64494 
B01 30000 282406 282406 
  B02 30000 315362 315362 
  B03 30000 320586 320586 
  B04 30000 311388 311388 
  B05 30000 295395 295395 305027 15763 
C01 10000 77605 77605 
  C02 10000 122547 122547 
  C03 10000 122942 122942 
  C04 10000 62531 62531 
  C05 10000 79186 79186 92962 27954 
D01 5000 52654 52654 
  D02 5000 32941 32941 
  D03 5000 23112 23112 
  D04 5000 49452 49452 
  D05 5000 37682 37682 39168 12108 
E01 1000 8368 8368 
  E02 1000 22198 22198 
  E03 1000 10944 10944 
  E04 1000 11476 11476 
  E05 1000 9868 9868 12571 5511 
F01 500 7592 7592 
  F02 500 7288 7288 
  F03 500 9790 9790 
  F04 500 7229 7229 
  F05 500 8002 8002 7980 1057 
G01 100 6048 6048 
  G02 100 6019 6019 
  G03 100 4848 4848 
  G04 100 6215 6215 
  G05 100 7477 7477 6121 933 
      H01 0 5381 
   H02 0 5583 
   H03 0 5797 
   H04 0 5900 
   H05 0 6459 5824 
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One Way Analysis of Variance (Microthread Std. Curve) Monday, August 11, 2008, 10:29:26 AM 
 
Data source: Data 8 in Notebook 1 
 
Normality Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Monday, August 11, 2008, 10:29:26 AM 
 
Data source: Data 8 in Notebook 1 
 
Group N  Missing  Median    25%      75%    
50,000 5 0 463496.000 429891.500 489851.750  
30,000 5 0 311388.000 292147.750 316668.000  
10,000 5 0 79186.000 73836.500 122645.750  
5,000 5 0 37682.000 30483.750 50252.500  
1,000 5 0 10944.000 9493.000 14156.500  
500 5 0 7592.000 7273.250 8449.000  
100 5 0 6048.000 5726.250 6530.500  
 
H = 33.059 with 6 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison procedure. 
 
 
All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) : 
 
Comparison Diff of Ranks q P<0.05   
50,000 vs 100 148.000 6.459 Yes   
50,000 vs 500 126.000 6.401 Yes   
50,000 vs 1,000 101.000 6.137 Yes   
50,000 vs 5,000 75.000 5.669 Yes   
50,000 vs 10,000 50.000 5.000 Yes   
50,000 vs 30,000 25.000 3.693 Yes   
30,000 vs 100 123.000 6.248 Yes   
30,000 vs 500 101.000 6.137 Yes   
30,000 vs 1,000 76.000 5.745 Yes   
30,000 vs 5,000 50.000 5.000 Yes   
30,000 vs 10,000 25.000 3.693 Yes   
10,000 vs 100 98.000 5.955 Yes   
10,000 vs 500 76.000 5.745 Yes   
10,000 vs 1,000 51.000 5.100 Yes   
10,000 vs 5,000 25.000 3.693 Yes   
5,000 vs 100 73.000 5.518 Yes   
5,000 vs 500 51.000 5.100 Yes   
5,000 vs 1,000 26.000 3.840 Yes   
1,000 vs 100 47.000 4.700 Yes   
1,000 vs 500 25.000 3.693 Yes   
500 vs 100 22.000 3.250 Yes   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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One Way Analysis of Variance (plated std curve) Monday, August 11, 2008, 11:34:07 AM 
 
Data source: Data 3 in Notebook 1 
 
Normality Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Monday, August 11, 2008, 11:34:07 AM 
 
Data source: Data 3 in Notebook 1 
 
Group N  Missing  Median    25%      75%     
50,000 5 0 1551097.000 1409591.000 1676978.000  
30,000 5 0 953864.000 784429.250 1036498.500  
10,000 5 0 264324.000 249962.750 283517.000  
5,000 5 0 99112.000 82623.500 100871.250  
1,000 5 0 22911.000 20719.000 26978.750  
500 5 0 14376.000 14234.250 15026.750  
100 5 0 7304.000 7261.750 7855.500  
 
H = 33.333 with 6 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would be expected by chance; there is a statistically 
significant difference  (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison procedure. 
 
 
All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) : 
 
Comparison Diff of Ranks q P<0.05   
50,000 vs 100 150.000 6.547 Yes   
50,000 vs 500 125.000 6.350 Yes   
50,000 vs 1,000 100.000 6.076 Yes   
50,000 vs 5,000 75.000 5.669 Yes   
50,000 vs 10,000 50.000 5.000 Yes   
50,000 vs 30,000 25.000 3.693 Yes   
30,000 vs 100 125.000 6.350 Yes   
30,000 vs 500 100.000 6.076 Yes   
30,000 vs 1,000 75.000 5.669 Yes   
30,000 vs 5,000 50.000 5.000 Yes   
30,000 vs 10,000 25.000 3.693 Yes   
10,000 vs 100 100.000 6.076 Yes   
10,000 vs 500 75.000 5.669 Yes   
10,000 vs 1,000 50.000 5.000 Yes   
10,000 vs 5,000 25.000 3.693 Yes   
5,000 vs 100 75.000 5.669 Yes   
5,000 vs 500 50.000 5.000 Yes   
5,000 vs 1,000 25.000 3.693 Yes   
1,000 vs 100 50.000 5.000 Yes   
1,000 vs 500 25.000 3.693 Yes   
500 vs 100 25.000 3.693 Yes   
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Appendix E: CyQuant Verification Data 
With the rinse step in the CyQuant protocol, unseeded threads showed no statistical difference 
from blank wells with just CyQuant dye.  
 
Thread control Blank Well 
   EXP3 4464 4481 
  
Thread Control  Blank Well 
 
4306 4410 
 
Average 4714 4664 
 
4106 4372 
 
Stdev 430.6894 290.0652 
 
4102 4442 
    
 
4171 4328 
    
 
4149 4405 
    
 
4677 4655 
  
 
4470 4498 
    
 
4574 4320 
    
 
4309 4452 
    
 
4201 4314 
    
 
4315 4176 
    
 
5562 5255 
    
 
4824 4791 
    
 
4844 4705 
    
 
4667 4638 
    
 
4840 4849 
    
 
4846 4602 
    EXP4 5057 4996 
    
 
4689 4897 
    
 
4519 4818 
    
 
4425 4617 
    
 
4423 4636 
    
  
4598 
    
 
5548 5173 
    
 
5266 4148 
    
 
5284 4860 
    
 
5422 4991 
    
 
4381 4983 
    
 
4972 4570 
    
 
4913 5323 
    
 
5008 4725 
    
 
4584 4503 
    
 
5385 4856 
    
 
5244 4958 
    
 
4456 4560 
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t-test Monday, August 11, 2008, 8:37:35 AM 
 
Data source: Data 4 in Notebook 1 
 
Normality Test: Passed (P = 0.150) 
 
Equal Variance Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test Monday, August 11, 2008, 8:37:35 AM 
 
Data source: Data 4 in Notebook 1 
 
Group N  Missing  Median    25%      75%     
Thread Control 36 1 4667.000 4391.500 4999.000  
Blank Well 36 0 4626.500 4447.000 4858.000  
 
T = 1272.000  n(small)= 35  n(big)= 36  (P = 0.895) 
 
The difference in the median values between the two groups is not great enough to exclude the possibility that the 
difference is due to random sampling variability; there is not a statistically significant difference  (P = 0.895) 
 
Analysis of the supernatant after centrifugation (left) and the PBS from rinses (right) indicates 
minimal cell loss and the presence of thread debris.  
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Appendix F: Microthreads CyQuant Data 
This appendix contains all of the raw data from the CyQuant assay on microthreads 
CyQuant EXP3 Day 
1 
      thread 
cntr 
plate 
cntr 
 
1d thread corr. #cells avg stdev 
4464 4481 
 
13816 9600 1016.914 1555.985 648.3004 
4306 4410 
 
11906 7690 814.5833 
  4106 4372 
 
15470 11254 1192.126 
  4102 4442 
 
21774 17558 1859.922 
  4171 4328 
 
27712 23496 2488.948 
  4149 4405 
 
22751 18535 1963.418 
  4216 4406 
      
        
   
1d plate corr. #cells avg stdev 
   
43165 38759 1258.807 962.2388 159.3185 
   
30746 26340 855.4617 
  
   
32240 27834 903.984 
  
   
34356 29950 972.7076 
  
   
34421 30015 974.8187 
  
   
29274 24868 807.654 
  
        
 
1000 
Cels 
Thread 
Control 
Thread 1 
Day Blank 
   
 
43165 4464 13816 4481 
   
 
30746 4306 11906 4410 
   
 
32240 4106 15470 4372 
   
 
34356 4102 21774 4442 
   
 
34421 4171 27712 4328 
   
 
29274 4149 22751 4405 
    
CyQuant EXP3 Day 
3 
      thread 
cntr 
plate 
cntr 
 
3 day 
thread corr. #cells avg stdev 
4677 4655 
 
15762 11338 1201.024 1861.352 790.1051 
4470 4498 
 
22892 18468 1956.321 
  4574 4320 
 
35753 31329 3318.715 
  4309 4452 
 
22374 17950 1901.448 
  4201 4314 
 
15319 10895 1154.096 
  4315 4176 
 
19873 15449 1636.511 
  4424 4403 
      
        
   
3 day plate corr. #cells avg stdev 
   
56751 52349 1700.179 1495.442 177.3922 
   
56051 51649 1677.444 
  
   
52497 48095 1562.017 
  
   
46852 42450 1378.678 
  
   
43368 38966 1265.525 
  
   
47164 42762 1388.811 
  
        
 
1000 
Cells 
Thread 
Control 
Thread 3 
Day Blank 
   
 
56751 4677 15762 4655 
   
 
56051 4470 22892 4498 
   
120 
 
 
52497 4574 35753 4320 
   
 
46852 4309 22374 4452 
   
 
43368 4201 15319 4314 
   
 
47164 4315 19873 4176 
    
        CyQuant EXP3 Day 
5 
      thread 
cntr 
plate 
cntr 
 
5day 
thread corr. #cells avg stdev 
5562 5255 
 
133460 128530 13615.41 4086.829 4695.578 
4824 4791 
 
19673 14743 1561.706 
  4844 4705 
 
25132 20202 2139.989 
  4667 4638 
 
29119 24189 2562.341 
  4840 4849 
 
32502 27572 2920.71 
  4846 4602 
 
21175 16245 1720.816 
  4931 4807 
      
        
   
5day plate corr. #cells avg stdev 
   
73295 68488 2224.369 1946.774 251.5261 
   
71725 66918 2173.379 
  
   
63589 58782 1909.137 
  
   
67286 62479 2029.209 
  
   
60004 55197 1792.703 
  
   
52588 47781 1551.846 
  
        
 
1000 
Cells 
Thread 
Control 
Thread 5 
Day Blank 
   
 
73295 5562 133460 5255 
   
 
71725 4824 19673 4791 
   
 
63589 4844 25132 4705 
   
 
67286 4667 29119 4638 
   
 
60004 4840 32502 4849 
   
 
52588 4846 21175 4602 
    
CyQuant EXP4 Day 
1 
      thread 
cntr 
plate 
cntr 
 
1 day 
thread corr. #cells avg stdev 
5057 4996 
 
22976 18353 1944.216 1619.181 624.4305 
4689 4897 
 
12619 7996 847.0763 
  4519 4818 
 
21179 16556 1753.856 
  4425 4617 
 
29281 24658 2612.119 
  4423 4636 
 
17431 12808 1356.822 
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15960 11337 1200.996 
  4623 4760 
      
        
   
1 day plate corr. #cells avg stdev 
   
24491 19731 640.8141 612.0223 50.29115 
   
24370 19610 636.8843 
  
   
21681 16921 549.5507 
  
   
24607 19847 644.5816 
  
   
24919 20159 654.7147 
  
   
21559 16799 545.5884 
  
        
 
1000 Thread Thread 1 Blank 
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Cells Control Day 
 
24491 5057 22976 4996 
   
 
24370 4689 12619 4897 
   
 
21681 4519 21179 4818 
   
 
24607 4425 29281 4617 
   
 
24919 4423 17431 4636 
   
 
21559   15960 4598 
    
CyQuant EXP4 Day 
3 
      thread 
cntr 
plate 
cntr 
 
3 day 
thread corr. #cells avg stdev 
5548 5173 
 
24220 19075 2020.604 1442.514 600.6925 
5266 4148 
 
12961 7816 827.9131 
  5284 4860 
 
22658 17513 1855.138 
  5422 4991 
 
21892 16747 1773.994 
  4381 4983 
 
20426 15281 1618.697 
  4972 4570 
 
10420 5275 558.7394 
  5146 4788 
      
        
   
3 day plate corr. #cells avg stdev 
   
25196 20409 662.8288 772.3557 71.92165 
   
28406 23619 767.0835 
  
   
31658 26871 872.7022 
  
   
27950 23163 752.2735 
  
   
30246 25459 826.8431 
  
   
27954 23167 752.4034 
  
        
 
1000 
Cells 
Thread 
Control 
Thread 3 
Day Blank 
   
 
25196 5548 24220 5173 
   
 
28406 5266 12961 4148 
   
 
31658 5284 22658 4860 
   
 
27950 5422 21892 4991 
   
 
30246 4381 20426 4983 
   
 
27954 4972 10420 4570 
    
CyQuant EXP4 Day 
5 
      thread 
cntr 
plate 
cntr 
 
5 day 
thread corr. #cells avg stdev 
4913 5323 
 
26739 21807 2310.099 3945.604 1603.839 
5008 4725 
 
45403 40471 4287.218 
  4584 4503 
 
42357 37425 3964.548 
  5385 4856 
 
35115 30183 3197.387 
  5244 4958 
 
33492 28560 3025.459 
  4456 4560 
 
69963 65031 6888.912 
  4932 4821 
      
        
   
5 day plate corr. #cells avg stdev 
   
28497 23676 768.9564 1081.547 224.7985 
   
38702 33881 1100.395 
  
   
40883 36062 1171.23 
  
   
37507 32686 1061.584 
  
   
49146 44325 1439.596 
  
   
33995 29174 947.5208 
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1000 
Cells 
Thread 
Control 
Thread 5 
Day Blank 
   
 
28497 4913 26739 5323 
   
 
38702 5008 45403 4725 
   
 
40883 4584 42357 4503 
   
 
37507 5385 35115 4856 
   
 
49146 5244 33492 4958 
   
 
33995 4456 69963 4560 
    
Raw Data Summary: Microthreads 
 
1 day  
 
3 day  
 
5 day  
EXP3 1016.9138 
 
1201.024 
 
13615.413 
 
814.58333 
 
1956.3206 
 
1561.7055 
 
1192.1257 
 
3318.7147 
 
2139.9894 
 
1859.9223 
 
1901.4477 
 
2562.3411 
 
2488.9477 
 
1154.096 
 
2920.7097 
 
1963.4181 
 
1636.5113 
 
1720.8157 
EXP4 1944.2161 
 
2020.6038 
 
2310.0989 
 
847.07627 
 
827.91314 
 
4287.2175 
 
1753.8559 
 
1855.1377 
 
3964.548 
 
2612.1186 
 
1773.9936 
 
3197.387 
 
1356.822 
 
1618.697 
 
3025.459 
 
1200.9958 
 
558.73941 
 
6888.9124 
Average 1587.583 
 
1651.9333 
 
4016.2164 
Stdev 607.75406 
 
703.99921 
 
3346.1456 
 
 
 
One Way Analysis of Variance Microthreads CyQuant Wednesday, August 13, 2008, 11:39:04 AM 
 
Data source: Data 4 in Thesis statistics 
 
Normality Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Wednesday, August 13, 2008, 11:39:04 AM 
 
Data source: Data 4 in Thesis statistics 
 
Group N  Missing  Median    25%      75%     
1 day 12 0 1555.339 1104.520 1953.817  
3 day 12 0 1705.252 1177.560 1928.884  
5 day 12 0 2973.084 2225.044 4125.883  
 
123 
 
H = 12.911 with 2 degrees of freedom.  (P = 0.002) 
 
The differences in the median values among the treatment groups are greater than would be expected by chance; 
there is a statistically significant difference  (P = 0.002) 
 
To isolate the group or groups that differ from the others use a multiple comparison procedure. 
 
 
All Pairwise Multiple Comparison Procedures (Tukey Test): 
 
Comparison Diff of Ranks q P<0.05   
5 day vs 1 day 164.000 4.494 Yes   
5 day vs 3 day 157.000 4.302 Yes   
3 day vs 1 day 7.000 0.192 No   
 
Note: The multiple comparisons on ranks do not include an adjustment for ties.. 
Raw Data Summary: plated hMSCs 
 
day 1 
 
day 3 
 
day 5 
EXP3 1258.807 
 
1700.1786 
 
2224.3694 
 
855.46173 
 
1677.444 
 
2173.3788 
 
903.98398 
 
1562.0169 
 
1909.1372 
 
972.70759 
 
1378.6781 
 
2029.2086 
 
974.81866 
 
1265.5245 
 
1792.7033 
 
807.654 
 
1388.8113 
 
1551.8458 
EXP4 640.81412 
 
662.82884 
 
768.95637 
 
636.88427 
 
767.08347 
 
1100.3951 
 
549.55072 
 
872.70218 
 
1171.2298 
 
644.58157 
 
752.27347 
 
1061.5838 
 
654.71473 
 
826.84313 
 
1439.5962 
 
545.58839 
 
752.40338 
 
947.52084 
EXP5 1573.3355 
 
559.74884 
 
1306.8854 
 
652.02988 
 
635.29284 
 
1269.1783 
 
1085.3849 
 
681.76897 
 
1368.9185 
 
749.78889 
 
716.71538 
 
1129.4251 
 
850.04872 
 
611.38898 
 
1372.1988 
 
644.39753 
 
579.13825 
 
1141.2147 
 
834.71906 
 
638.021 
 
1371.4193 
 
638.74635 
 
610.64198 
 
1129.8149 
 
816.79117 
 
606.74461 
 
1206.723 
 
731.73108 
 
610.57703 
 
1113.8681 
 
738.84378 
 
559.61892 
 
995.42059 
 
745.3394 
 
522.464 
 
962.35791 
avg 812.78012 
 
872.45453 
 
1355.7229 
stdev 235.45373 
 
385.82977 
 
397.82862 
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One Way Analysis of Variance: Plated hMSCs CyQuant Tuesday, August 12, 2008, 9:34:06 AM 
 
Data source: Data 8 in Thesis statistics 
 
Normality Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Tuesday, August 12, 2008, 9:34:06 AM 
 
Data source: Data 8 in Thesis statistics 
 
Group N  Missing  Median    25%      75%     
1 day 24 0 747.564 644.490 879.723  
3 day 24 0 699.242 610.610 1069.113  
5 day 24 0 1237.951 1107.132 1495.721  
 
H = 25.533 with 2 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would be expected by chance; 
there is a statistically significant difference  (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison procedure. 
 
 
All Pairwise Multiple Comparison Procedures (Tukey Test): 
 
Comparison Diff of Ranks q P<0.05   
5 day vs 3 day 636.000 6.203 Yes   
5 day vs 1 day 633.000 6.174 Yes   
1 day vs 3 day 3.000 0.0293 No   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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Fibrin Coated Data 
CyQuant EXP4 Day 
1 
     1 day 
fibrin corr. #cells avg stdev 
 
plate 
cntr 
11030 6270 664.1596 649.0466 213.8303 
 
4996 
12588 7828 829.202 
   
4897 
14927 10167 1076.977 
   
4818 
9004 4244 449.541 
   
4617 
8773 4013 425.0706 
   
4636 
11186 6426 680.685 
   
4598 
12245 7485 792.8672 
   
4760 
12933 8173 865.7486 
    10870 6110 647.2105 
    8483 3723 394.3503 
    8729 3969 420.4096 
    9880 5120 542.3376 
    
       
 
1000 
Cells 
Fibrin 3 
Day 
Fibrin 3 
Day  Blank 
  
 
24491 11030 12245 4996 
  
 
24370 12588 12933 4897 
  
 
21681 14927 10870 4818 
  
 
24607 9004 8483 4617 
  
 
24919 8773 8729 4636 
  
 
21559 11186 9880 4598 
   
CyQuant EXP4 Day 
3 
     3 day 
fibrin corr. #cells avg stdev 
 
plate 
cntr 
6005 1218 128.9725 157.6801 101.1262 
 
5173 
6758 1971 208.7394 
   
4148 
8271 3484 369.0148 
   
4860 
5735 948 100.3708 
   
4991 
6742 1955 207.0445 
   
4983 
5518 731 77.38347 
   
4570 
6339 1552 164.3538 
   
4788 
5680 893 94.54449 
    7550 2763 292.6377 
    6459 1672 177.0657 
    5112 325 34.375 
    5143 356 37.6589 
    
       
 
1000 
Cells 
Fibrin 3 
Day 
Fibrin 3 
Day Blank 
  
 
25196 6005 6339 5173 
  
 
28406 6758 5143 4148 
  
 
31658 8271 5680 4860 
  
 
27950 5735 7550 4991 
  
 
30246 6742 6459 4983 
  
 
27954 5518 5112 4570 
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CyQuant EXP4 Day 
5 
     5 day 
fibrin corr. #cells avg stdev 
 
plate 
cntr 
23172 18351 1943.98 1235.593 759.2922 
 
5323 
21471 16650 1763.789 
   
4725 
15055 10234 1084.128 
   
4503 
29951 25130 2662.094 
   
4856 
24235 19414 2056.585 
   
4958 
16548 11727 1242.285 
   
4560 
18742 13921 1474.7 
   
4821 
8248 3427 363.0473 
    9593 4772 505.5261 
    7693 2872 304.2549 
    9857 5036 533.4922 
    13253 8432 893.238 
    
       
 
1000 
Cells 
Fibrin 5 
Day 
Fibrin 5 
Day Blank 
  
 
28497 23172 18742 5323 
  
 
38702 21471 8248 4725 
  
 
40883 15055 9593 4503 
  
 
37507 29951 7693 4856 
  
 
49146 24235 9857 4958 
  
 
33995 16548 13253 4560 
   
CyQuant EXP 6 3 and 5 Day 
        3 day 
plate corr. #cells avg stdev 
 
5 day 
plate corr. #cells avg stdev 
14189 9392 305.0179 436.3051 151.231 
 
6344 1547 50.22735 95.41518 25.6801 
13875 9078 294.8197 
   
8418 3621 117.5869 
  15384 10587 343.8292 
   
8191 3394 110.2144 
  22515 17718 575.4303 
   
8348 3551 115.3134 
  25059 20262 658.0546 
   
7360 2563 83.22507 
  18366 13569 440.6788 
   
7751 2954 95.924 
  
           3 day 
fibrin corr. #cells avg stdev 
 
5 day 
fibrin corr. #cells avg stdev 
18984 14187 1502.807 1841.278 886.0348 
 
16329 11532 1221.557 1979.908 1038.095 
29713 24916 2639.354 
   
34453 29656 3141.472 
  16502 11705 1239.883 
   
37599 32802 3474.735 
  20549 15752 1668.591 
   
30348 25551 2706.621 
  13465 8668 918.1674 
   
35321 30524 3233.422 
  11146 6349 672.5106 
   
23742 18945 2006.833 
  22135 17338 1836.6 
   
17806 13009 1378.019 
  17576 12779 1353.655 
   
17648 12851 1361.282 
  28150 23353 2473.782 
   
7657 2860 302.9131 
  33330 28533 3022.511 
   
17572 12775 1353.231 
  38172 33375 3535.434 
   
30060 25263 2676.112 
  16428 11631 1232.044 
   
13319 8522 902.7013 
  
           
plate cntr 
 
Fibrin 3 
Day 
Fibrin 3 
Day 
1000 3 
Day 
Fibrin 
5 Day 
Fibrin 
5 Day 
1000 5 
Day Blank 
  5061 
 
18984 22135 14189 16329 17806 6344 5061 
  4637 
 
29713 17576 13875 34453 17648 8418 4637 
  4538 
 
16502 28150 15384 37599 7657 8191 4538 
  4898 
 
20549 33330 22515 30348 17572 8348 4898 
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4772 
 
13465 38172 25059 35321 30060 7360 4772 
  4879 
 
11146 16428 18366 23742 13319 7751 4879 
  4798 
           
Summary Data: Fibrin Coated Plate 
 
1 day 3 day 5 day 
EXP3 664.1596 128.97246 1943.9795 
 
829.20198 208.73941 1763.7888 
 
1076.9774 369.01483 1084.1278 
 
449.54096 100.37076 2662.0939 
 
425.07062 207.04449 2056.5855 
 
680.68503 77.383475 1242.2846 
 
792.86723 164.35381 1474.6999 
 
865.74859 94.544492 363.04732 
 
647.21045 292.63771 505.52613 
 
394.35028 177.06568 304.25494 
 
420.4096 34.375 533.49223 
 
542.33757 37.658898 893.23799 
EXP6 
 
1502.8072 1221.5572 
  
2639.3538 3141.4725 
  
1239.8835 3474.7352 
  
1668.5911 2706.6208 
  
918.16737 3233.4216 
  
672.51059 2006.8326 
  
1836.5996 1378.0191 
  
1353.6547 1361.2818 
  
2473.7818 302.91314 
  
3022.5106 1353.2309 
  
3535.4343 2676.1123 
  
1232.0445 902.70127 
Average 649.04661 999.47917 1607.7507 
Stdev 213.83028 1058.2008 967.28774 
 
 
One Way Analysis of Variance: Fibrin coated plate CyQuant Tuesday, August 12, 2008, 9:28:54 AM 
 
Data source: Data 9 in Thesis statistics 
 
Normality Test: Passed (P = 0.175) 
 
Equal Variance Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
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Kruskal-Wallis One Way Analysis of Variance on Ranks Tuesday, August 12, 2008, 9:28:54 AM 
 
Data source: Data 9 in Thesis statistics 
 
Group N  Missing  Median    25%      75%     
1 day 12 0 655.685 437.306 811.035  
3 day 24 0 520.763 146.663 1585.699  
5 day 24 0 1369.650 897.970 2359.340  
 
H = 10.121 with 2 degrees of freedom.  (P = 0.006) 
 
The differences in the median values among the treatment groups are greater than would be expected by chance; 
there is a statistically significant difference  (P = 0.006) 
 
To isolate the group or groups that differ from the others use a multiple comparison procedure. 
 
 
All Pairwise Multiple Comparison Procedures (Dunn's Method) : 
 
Comparison Diff of Ranks Q P<0.05   
5 day vs 1 day 15.750 2.551 Yes   
5 day vs 3 day 14.000 2.777 Yes   
3 day vs 1 day 1.750 0.283 No   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties.  
129 
 
Appendix G: Ki-67 Expression 
Raw Data from Ki-67 expression counts:  
Bundles 
          
Day 1 
 
Day 3 
 
Day 5 
Total Cells 
Ki-67 
positive 
Expression 
Rate  
Total 
Cells 
Ki-67 
positive 
Expression 
Rate  
Total 
Cells 
Ki-67 
positive 
Expression 
Rate 
66 1 1.515151515 
 
25 8 32 
 
82 4 4.87804878 
35 1 2.857142857 
 
142 31 21.83098592 
 
58 4 6.896551724 
29 1 3.448275862 
 
112 28 25 
 
84 15 17.85714286 
28 0 0 
 
75 10 13.33333333 
 
81 12 14.81481481 
6 1 16.66666667 
 
100 23 23 
 
62 4 6.451612903 
10 1 10 
 
118 30 25.42372881 
 
60 3 5 
91 3 3.296703297 
 
191 34 17.80104712 
 
49 0 0 
80 5 6.25 
 
38 10 26.31578947 
 
64 3 4.6875 
78 0 0 
 
42 5 11.9047619 
 
53 4 7.547169811 
74 2 2.702702703 
 
75 6 8 
 
49 0 0 
           
 
average 4.892660022 
  
average 22.6270136 
  
average 6.813284089 
 
stdev 5.415429201 
  
stdev 5.940549621 
  
stdev 5.68684067 
 
Standard Chamber 
Slides          
Day 1 
 
Day 3 
 
Day 5 
Total 
Cells 
Ki-67 
positive 
Expression 
Rate  
Total 
Cells 
Ki-67 
positive 
Expression 
Rate  
Total 
Cells 
Ki-67 
positive 
Expression 
Rate 
18 4 22.22222222 
 
46 7 15.2173913 
 
46 8 17.39130435 
19 2 10.52631579 
 
44 19 43.18181818 
 
61 11 18.03278689 
16 4 25 
 
44 16 36.36363636 
 
53 14 26.41509434 
37 7 18.91891892 
 
40 9 22.5 
 
50 10 20 
22 0 0 
 
25 6 24 
 
70 20 28.57142857 
21 0 0 
 
14 3 21.42857143 
 
53 17 32.0754717 
25 0 0 
 
21 8 38.0952381 
 
12 7 58.33333333 
27 0 0 
 
24 1 4.166666667 
 
12 4 33.33333333 
10 2 20 
 
23 3 13.04347826 
 
15 3 20 
17 1 5.882352941 
 
12 4 33.33333333 
 
14 5 35.71428571 
           
 
average 10.25498099 
  
average 26.23474915 
  
average 28.98670382 
 
stdev 10.38434561 
  
stdev 12.66841689 
  
stdev 12.28218042 
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Fibrin Coated Chamber Slides 
        
Day 1 
 
Day 3 
 
Day 5 
Total 
Cells 
Ki-67 
positive 
Expression 
Rate  
Total 
Cells 
Ki-67 
positive 
Expression 
Rate  
Total 
Cells 
Ki-67 
positive 
Expression 
Rate 
4 1 25 
 
26 7 26.92307692 
 
21 4 19.04761905 
12 1 8.333333333 
 
21 6 28.57142857 
 
19 2 10.52631579 
16 5 31.25 
 
24 7 29.16666667 
 
28 8 28.57142857 
9 2 22.22222222 
 
16 4 25 
 
27 5 18.51851852 
8 4 50 
 
22 1 4.545454545 
 
24 5 20.83333333 
6 0 0 
 
21 2 9.523809524 
 
27 6 22.22222222 
10 1 10 
 
14 7 50 
 
28 3 10.71428571 
16 0 0 
 
12 6 50 
 
22 3 13.63636364 
25 1 4 
 
8 4 50 
 
17 5 29.41176471 
2 1 50 
 
17 10 58.82352941 
 
26 9 34.61538462 
           
 
average 20.08055556 
  
average 33.25539656 
  
average 20.80972362 
 
stdev 18.99867537 
  
stdev 18.34614933 
  
stdev 8.126152771 
 
 
One Way Analysis of Variance Bundles Ki-67 Wednesday, August 13, 2008, 5:07:41 PM 
 
Data source: Data 13 in Thesis statistics 
 
Normality Test: Passed (P = 0.417) 
 
Equal Variance Test: Passed (P = 0.382) 
 
Group Name  N  Missing Mean Std Dev SEM  
1 day 10 0 4.674 5.152 1.629  
3 day 10 0 20.461 7.508 2.374  
5 day 10 0 6.813 5.687 1.798  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 2 1466.920 733.460 19.091 <0.001  
Residual 27 1037.339 38.420    
Total 29 2504.259     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
3 day vs. 1 day 15.787 5.695 0.00000474 0.017 Yes  
3 day vs. 5 day 13.648 4.923 0.0000374 0.025 Yes  
5 day vs. 1 day 2.140 0.772 0.447 0.050 No  
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One Way Analysis of Variance Std Chamber Slide Ki-67 Wednesday, August 13, 2008, 5:12:56 PM 
 
Data source: Data 12 in Thesis statistics 
 
Normality Test: Passed (P = 0.108) 
 
Equal Variance Test: Passed (P = 0.920) 
 
Group Name  N  Missing Mean Std Dev SEM  
1 day 10 0 10.255 10.384 3.284  
3 day 10 0 25.133 12.442 3.934  
5 day 10 0 28.987 12.282 3.884  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 2 1956.947 978.474 7.099 0.003  
Residual 27 3721.334 137.827    
Total 29 5678.281     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference  (P = 0.003). 
 
Power of performed test with alpha = 0.050: 0.859 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?  
5 day vs. 1 day 18.732 3.568 0.00137 0.017 Yes  
3 day vs. 1 day 14.878 2.834 0.00860 0.025 Yes  
5 day vs. 3 day 3.854 0.734 0.469 0.050 No  
 
 
One Way Analysis of Variance Fibrin Coated Ch Slide Wednesday, August 13, 2008, 5:19:24 PM 
 
Data source: Data 11 in Thesis statistics 
 
Normality Test: Passed (P = 0.803) 
 
Equal Variance Test: Passed (P = 0.070) 
 
Group Name  N  Missing Mean Std Dev SEM  
1 day 10 0 20.081 18.999 6.008  
3 day 10 0 33.255 18.346 5.802  
5 day 10 0 20.810 8.126 2.570  
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 2 1096.676 548.338 2.154 0.135  
Residual 27 6872.087 254.522    
Total 29 7968.763     
 
The differences in the mean values among the treatment groups are not great enough to exclude the possibility that 
the difference is due to random sampling variability; there is not a statistically significant difference  (P = 0.135). 
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Power of performed test with alpha = 0.050: 0.223 
 
The power of the performed test (0.223) is below the desired power of 0.800. 
Less than desired power indicates you are more likely to not detect a difference when one actually exists. Be 
cautious in over-interpreting the lack of difference found here. 
 
Comparison of Ki-67 expression on different substrates by day: 
 
One Way Analysis of Variance Wednesday, August 13, 2008, 5:47:16 PM 
 
Data source: Data 14 in Thesis statistics 
 
Normality Test: Passed (P = 0.510) 
 
Equal Variance Test: Failed (P < 0.050) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Wednesday, August 13, 2008, 5:47:16 PM 
 
Data source: Data 14 in Thesis statistics 
 
Group N  Missing  Median    25%      75%     
1 day M 10 0 3.077 1.515 6.250  
1 day Uncoat 10 0 8.204 0.000 20.000  
1 day Fibrin coat 10 0 16.111 4.000 31.250  
 
H = 3.973 with 2 degrees of freedom.  (P = 0.137) 
 
The differences in the median values among the treatment groups are not great enough to exclude the possibility that 
the difference is due to random sampling variability; there is not a statistically significant difference    (P = 0.137) 
 
 
One Way Analysis of Variance Wednesday, August 13, 2008, 5:47:41 PM 
 
Data source: Data 14 in Thesis statistics 
 
Normality Test: Passed (P = 0.817) 
 
Equal Variance Test: Passed (P = 0.089) 
 
Group Name  N  Missing Mean Std Dev SEM  
3 day microthread 10 0 20.461 7.508 2.374 
3 day uncoat 10 0 25.133 12.442 3.934 
3 day fibrin coat 10 0 33.255 18.346 5.802 
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 2 838.329 419.164 2.296 0.120  
Residual 27 4929.731 182.583    
Total 29 5768.060     
 
The differences in the mean values among the treatment groups are not great enough to exclude the possibility that 
the difference is due to random sampling variability; there is not a statistically significant difference  (P = 0.120). 
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Power of performed test with alpha = 0.050: 0.247 
 
The power of the performed test (0.247) is below the desired power of 0.800. 
Less than desired power indicates you are more likely to not detect a difference when one actually exists. Be 
cautious in over-interpreting the lack of difference found here. 
 
 
One Way Analysis of Variance Wednesday, August 13, 2008, 5:48:07 PM 
 
Data source: Data 14 in Thesis statistics 
 
Normality Test: Passed (P = 0.147) 
 
Equal Variance Test: Passed (P = 0.237) 
 
Group Name  N  Missing Mean Std Dev SEM  
5 day microthread 10 0 6.813 5.687 1.798 
5 day uncoat 10 0 28.987 12.282 3.884 
5 day fibrin coat 10 0 20.810 8.126 2.570 
 
Source of Variation  DF   SS   MS    F    P   
Between Groups 2 2514.746 1257.373 15.135 <0.001  
Residual 27 2243.038 83.075    
Total 29 4757.784     
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference  (P = <0.001). 
 
Power of performed test with alpha = 0.050: 0.998 
 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?
  
5 day uncoat vs. 5 day microt 22.173 5.440 0.00000937 0.017 Yes  
5 day fibrin vs. 5 day microt 13.996 3.434 0.00194 0.025 Yes  
5 day uncoat vs. 5 day fibrin 8.177 2.006 0.0550 0.050 No  
 
 
 
 
 
 
 
 
 
 
